Vanguard Specialized Funds

10/01/2026 | Press release | Distributed by Public on 10/01/2026 07:45

Semi-Annual Report by Investment Company (Form N-CSRS)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT

OF

REGISTERED MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number: 811-03916

Name of Registrant: Vanguard Specialized Funds
Address of Registrant: P.O. Box 2600
Valley Forge, PA 19482
Name and address of agent for service: Natalie Lamarque, Esquire
P.O. Box 876
Valley Forge, PA 19482

Registrant's telephone number, including area code: (610) 669-1000

Date of fiscal year end: January 31

Date of reporting period: February 1, 2026-July 31, 2026

Item 1: Reports to Shareholders.

TABLE OF CONTENTS

Dividend Growth Fund
Investor Shares - VDIGX

   

Energy Opportunities Fund
Investor Shares - VGENX

   

Energy Opportunities Fund
Admiral™ Shares - VGELX

   

Health Care Fund
Investor Shares - VGHCX

   

Health Care Fund
Admiral™ Shares - VGHAX

   

Dividend Appreciation Index Fund
ETF Shares - VIG

   

Dividend Appreciation Index Fund
Admiral™ Shares - VDADX

   

Vanguard Dividend Growth Fund

Investor Shares (VDIGX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Dividend Growth Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$10
0.19%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$35,481
Number of Portfolio Holdings
70
Portfolio Turnover Rate
25%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Communication Services
1.5%
Consumer Discretionary
7.7%
Consumer Staples
6.2%
Energy
2.7%
Financials
21.4%
Health Care
17.6%
Industrials
12.9%
Information Technology
24.7%
Materials
2.6%
Utilities
1.7%
Other Assets and Liabilities-Net
1.0%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR57

Vanguard Energy Opportunities Fund

Investor Shares (VGENX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Energy Opportunities Fund (the "Fund") (formerly known as Vanguard Energy Fund) for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$23
0.44%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$7,311
Number of Portfolio Holdings
43
Portfolio Turnover Rate
8%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Asia
2.8%
Europe
32.2%
North America
63.4%
South America
1.1%
Other Assets and Liabilities-Net
0.5%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR51

Vanguard Energy Opportunities Fund

Admiral™ Shares (VGELX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Energy Opportunities Fund (the "Fund") (formerly known as Vanguard Energy Fund) for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$19
0.36%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$7,311
Number of Portfolio Holdings
43
Portfolio Turnover Rate
8%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Asia
2.8%
Europe
32.2%
North America
63.4%
South America
1.1%
Other Assets and Liabilities-Net
0.5%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR551

Vanguard Health Care Fund

Investor Shares (VGHCX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Investor Shares
$17
0.34%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$38,166
Number of Portfolio Holdings
97
Portfolio Turnover Rate
24%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Asia
5.5%
Europe
18.2%
North America
74.1%
Other Assets and Liabilities-Net
2.2%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR52

Vanguard Health Care Fund

Admiral™ Shares (VGHAX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Health Care Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$14
0.28%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$38,166
Number of Portfolio Holdings
97
Portfolio Turnover Rate
24%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Asia
5.5%
Europe
18.2%
North America
74.1%
Other Assets and Liabilities-Net
2.2%

This table reflects the Fund's investments, including short-term investments and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR552

Vanguard Dividend Appreciation Index Fund

ETF Shares (VIG) NYSE Arca

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
ETF Shares
$2
0.04%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$130,900
Number of Portfolio Holdings
340
Portfolio Turnover Rate
4%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Consumer Discretionary
4.2%
Consumer Staples
9.3%
Energy
3.3%
Financials
21.8%
Health Care
17.7%
Industrials
11.9%
Information Technology
25.3%
Materials
3.2%
Utilities
2.9%
Other Assets and Liabilities-Net
0.4%

This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR920

Vanguard Dividend Appreciation Index Fund

Admiral™ Shares (VDADX)

Semi-Annual Shareholder Report | July 31, 2026

This semi-annual shareholder report contains important information about Vanguard Dividend Appreciation Index Fund (the "Fund") for the period of February 1, 2026, to July 31, 2026. You can find additional information about the Fund at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature. You can also request this information by contacting us at 800-662-7447.

What were the Fund costs for the last six months?

(based on a hypothetical $10,000 investment)

Table Summary
Share Class Name
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Admiral Shares
$4
0.07%Footnote Reference1
Footnote Description
Footnote1
Annualized.

Fund Statistics (as of July 31, 2026)

Table Summary
Fund Net Assets (in millions)
$130,900
Number of Portfolio Holdings
340
Portfolio Turnover Rate
4%

Portfolio Composition % of Net Assets (as of July 31, 2026)

Table Summary
Consumer Discretionary
4.2%
Consumer Staples
9.3%
Energy
3.3%
Financials
21.8%
Health Care
17.7%
Industrials
11.9%
Information Technology
25.3%
Materials
3.2%
Utilities
2.9%
Other Assets and Liabilities-Net
0.4%

This table reflects the Fund's investments, including short-term investments, derivatives and other assets and liabilities.

Where can I find additional information about the Fund?

Additional information about the Fund, including its prospectus, financial information, holdings, and proxy voting information is available at https://personal1.vanguard.com/ngf-next-gen-form-webapp/fund-literature.

Connect with Vanguard® • vanguard.com

Fund Information • 800-662-7447

Direct Investor Account Services • 800-662-2739

Text Telephone for People Who Are Deaf or Hard of Hearing •

800-749-7273

© 2026 The Vanguard Group, Inc.

All rights reserved.

Vanguard Marketing Corporation, Distributor.

SR5702

Item 2: Code of Ethics.

Not applicable.

Item 3: Audit Committee Financial Expert.

Not applicable.

Item 4: Principal Accountant Fees and Services.

Not applicable.

Item 5: Audit Committee of Listed Registrants.

Not applicable.

Item 6: Investments.

Not applicable. The complete schedule of investments is included in the financial statements filed under Item 7 of this Form.

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.

 
Financial Statements
For the six-months ended July 31, 2026
Vanguard Dividend Growth Fund
 
Contents 
Financial Statements
1
 
 
Dividend Growth Fund
Financial Statements (unaudited)
Schedule of Investments
As of July 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund's Form N-PORT reports are available on the SEC's website at www.sec.gov. 
Shares
Market
Value•
($000)
Common Stocks (99.0%)
Communication Services (1.5%)
 
Alphabet Inc. Class A
 1,489,258
   530,369
Consumer Discretionary (7.7%)
 
Home Depot Inc.
 2,636,912
   875,349
 
TJX Cos. Inc.
 5,068,526
   797,482
 
McDonald's Corp.
 1,514,980
   410,014
 
Marriott International Inc. Class A
 1,006,301
   375,179
 
NIKE Inc. Class B
 6,852,981
   285,838
 
          
 2,743,862
Consumer Staples (6.2%)
 
Coca-Cola Co.
 7,303,254
   639,692
 
Unilever plc
 7,058,887
   449,140
 
Procter & Gamble Co.
 2,822,324
   407,798
 
PepsiCo Inc.
 1,383,735
   193,114
 
Walmart Inc.
 1,602,004
   178,143
*
US Foods Holding Corp.
 1,449,905
   145,846
 
Colgate-Palmolive Co.
 1,345,935
   122,884
 
Kroger Co.
   881,025
    50,870
 
          
 2,187,487
Energy (2.7%)
 
ExxonMobil Holdings Corp.
 4,275,096
   664,521
 
TotalEnergies SE (XNYS) ADR
 3,422,073
   300,663
 
          
   965,184
Financials (21.4%)
 
Mastercard Inc. Class A
 2,466,952
 1,413,810
 
Visa Inc. Class A (XNYS)
 3,355,458
 1,228,534
 
Blackrock Inc.
   970,963
 1,058,729
 
Wells Fargo & Co.
11,550,584
   998,548
 
Marsh & McLennan Cos. Inc.
 4,623,171
   876,969
 
Chubb Ltd.
 2,121,141
   743,842
 
JPMorgan Chase & Co. (XNYS)
 1,829,631
   643,646
 
S&P Global Inc.
   816,479
   336,332
 
UBS Group AG (Registered)
 5,740,784
   303,444
 
          
 7,603,854
Health Care (17.6%)
 
Eli Lilly & Co.
 1,438,568
 1,652,684
 
Merck & Co. Inc.
 7,319,240
   952,965
 
Stryker Corp.
 2,235,827
   728,209
 
Danaher Corp.
 3,526,208
   687,540
 
Johnson & Johnson
 2,515,972
   644,969
 
Amgen Inc.
 1,359,131
   523,483
 
Elevance Health Inc. (XNYS)
 1,261,543
   474,138
 
Cardinal Health Inc.
 1,476,901
   339,732
 
AbbVie Inc.
   763,096
   191,491
 
AstraZeneca plc ADR
   189,516
    32,150
 
          
 6,227,361
Industrials (12.9%)
 
Automatic Data Processing Inc.
 3,198,960
   852,395
 
Northrop Grumman Corp.
 1,162,288
   630,518
 
Trane Technologies plc
 1,189,724
   541,265
 
AMETEK Inc.
 2,009,236
   485,652
 
Honeywell International Inc.
 1,976,001
   480,267
 
Canadian National Railway Co.
 3,327,692
   423,127
*
Honeywell Aerospace Inc.
 1,976,001
   408,519
 
Caterpillar Inc. (XNYS)
   434,270
   353,848
 
Deere & Co.
   596,545
   353,554
 
Waste Management Inc.
    77,639
    17,589
 
Rollins Inc.
   399,038
    15,152
1
Dividend Growth Fund
Shares
Market
Value•
($000)
 
CH Robinson Worldwide Inc.
    94,429
    13,950
 
          
 4,575,836
Information Technology (24.7%)
 
Broadcom Inc.
 5,352,977
 2,083,807
 
Microsoft Corp.
 4,415,608
 2,052,021
 
Apple Inc.
 3,819,120
 1,179,765
 
Texas Instruments Inc.
 3,834,345
 1,057,282
 
KLA Corp.
 3,576,072
   653,778
 
Amphenol Corp. Class A
 3,941,906
   633,464
 
International Business Machines Corp.
 1,534,693
   343,234
 
QUALCOMM Inc.
 2,053,830
   303,166
 
ASML Holding NV GDR (Registered)
   142,807
   232,633
 
NVIDIA Corp.
 1,112,425
   223,319
 
          
 8,762,469
Materials (2.6%)
 
Linde plc
 1,711,385
   818,692
*
Glencore plc
15,353,310
   113,083
 
          
   931,775
Utilities (1.7%)
 
American Water Works Co. Inc.
 2,716,844
   364,519
 
Sempra
 1,947,863
   172,483
 
Dominion Energy Inc.
   774,751
    53,590
 
          
   590,592
Total Common Stocks (Cost $20,022,285)
35,118,789
Temporary Cash Investments (1.1%)
Money Market Fund (0.0%)
1
Vanguard Market Liquidity Fund, 3.718% 
       262
        26
Face
Amount
($000)

Repurchase Agreements (1.1%)
 
Bank of America Securities, LLC 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $20,006, collateralized by U.S. Treasury Obligations 0.000%-4.625%, 8/6/2026-11/15/2055, with a
value of $20,400)
    20,000
    20,000
 
Bank of America Securities, LLC 3.660%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $35,011, collateralized by U.S. Government Agency Obligations 3.000%-6.000%,
12/1/2040-4/1/2056, with a value of $35,700)
    35,000
    35,000
 
Credit Agricole Securities 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $77,323, collateralized by U.S. Treasury and Government Agency Obligations 0.000%-5.400%,
10/31/2026-8/15/2054, with a value of $78,846)
    77,300
    77,300
 
JP Morgan Securities, LLC 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $55,017, collateralized by U.S. Treasury Obligations 4.625%, 6/15/2027, with a value of $56,100)
    55,000
    55,000
 
Natixis SA 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $64,119, collateralized by U.S. Treasury and Government Agency Obligations 0.500%-4.875%,
12/31/2026-11/15/2055, with a value of $65,382)
    64,100
    64,100
 
Nomura International plc 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $75,023, collateralized by U.S. Treasury Obligations 3.750%-4.250%, 7/31/2028-5/31/2031, with a
value of $76,500)
    75,000
    75,000
 
Societe Generale 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $75,723, collateralized by U.S. Treasury Obligations 3.375%-4.625%, 2/15/2040-8/15/2042, with a
value of $77,214)
    75,700
    75,700
 
          
   402,100
Total Temporary Cash Investments (Cost $402,126)
402,126
Total Investments (100.1%) (Cost $20,424,411)
35,520,915
Other Assets and Liabilities-Net (-0.1%)
(40,139)
Net Assets (100%)
35,480,776
Cost is in $000.
 
•
See Note A in Notes to Financial Statements.
*
Non-income-producing security.
1
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
ADR-American Depositary Receipt.
GDR-Global Depositary Receipt.
 
See accompanying Notes, which are an integral part of the Financial Statements.
2
Dividend Growth Fund
Statement of Assets and Liabilities
As of July 31, 2026
 
($000s, except shares and per-share amounts)
Amount
Assets
Investments in Securities, at Value
Unaffiliated Issuers (Cost $20,424,385)
35,520,889
Affiliated Issuers (Cost $26)
26
Total Investments in Securities
35,520,915
Investment in Vanguard
763
Cash
40
Foreign Currency, at Value (Cost $29)
29
Receivables for Investment Securities Sold
124,574
Receivables for Accrued Income
23,694
Receivables for Capital Shares Issued
3,185
Total Assets
35,673,200
Liabilities
Payables for Investment Securities Purchased
160,617
Payables to Investment Advisor
4,000
Payables for Capital Shares Redeemed
25,629
Payables to Vanguard
2,178
Total Liabilities
192,424
Net Assets
35,480,776
At July 31, 2026, net assets consisted of:
Paid-in Capital
16,999,515
Total Distributable Earnings (Loss)
18,481,261
Net Assets
35,480,776
Net Assets
Applicable to 1,112,031,391 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
35,480,776
Net Asset Value Per Share
$31.91
  See accompanying Notes, which are an integral part of the Financial Statements.
3
Dividend Growth Fund
Statement of Operations
 
Six Months Ended
July 31, 2026
($000)
Investment Income
Income
Dividends1
272,431
Interest
7,619
Securities Lending-Net
1
Total Income
280,051
Expenses
Investment Advisory Fees-Note B
Basic Fee
24,265
Performance Adjustment
(15,674
)
The Vanguard Group-Note C
Management and Administrative
24,242
Marketing and Distribution
977
Custodian Fees
119
Shareholders' Reports
167
Trustees' Fees and Expenses
9
Other Expenses
73
Total Expenses
34,178
Expenses Paid Indirectly
(44
)
Net Expenses
34,134
Net Investment Income
245,917
Realized Net Gain (Loss)
Investment Securities Sold2
3,404,368
Foreign Currencies
(155
)
Realized Net Gain (Loss)
3,404,213
Change in Unrealized Appreciation (Depreciation)
Investment Securities2
(2,340,987
)
Foreign Currencies
(81
)
Change in Unrealized Appreciation (Depreciation)
(2,341,068
)
Net Increase (Decrease) in Net Assets Resulting from Operations
1,309,062
 
1
Dividends are net of foreign withholding taxes of $1,162.
2
Change in unrealized appreciation (depreciation) from an affiliated company of the fund was less than $1. There was no realized net gain (loss) during the period. Purchases and sales are for temporary cash investment
purposes.
  See accompanying Notes, which are an integral part of the Financial Statements.
4
Dividend Growth Fund
Statement of Changes in Net Assets
 
Six Months Ended
July 31,
2026
Year Ended
January 31,
2026
($000)
($000)
Increase (Decrease) in Net Assets
Operations
Net Investment Income
245,917
685,976
Realized Net Gain (Loss)
3,404,213
8,742,302
Change in Unrealized Appreciation (Depreciation)
(2,341,068
)
(6,632,028
)
Net Increase (Decrease) in Net Assets Resulting from Operations
1,309,062
2,796,250
Distributions
Total Distributions
(2,716,738
)
(7,277,528
)
Capital Share Transactions
Issued
542,862
2,455,621
Issued in Lieu of Cash Distributions
2,382,302
6,339,899
Redeemed
(6,376,040
)
(14,399,407
)
Net Increase (Decrease) from Capital Share Transactions
(3,450,876
)
(5,603,887
)
Total Increase (Decrease)
(4,858,552
)
(10,085,165
)
Net Assets
Beginning of Period
40,339,328
50,424,493
End of Period
35,480,776
40,339,328
  See accompanying Notes, which are an integral part of the Financial Statements.
5
Dividend Growth Fund
Financial Highlights
 
  
For a Share Outstanding
Throughout Each Period
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$33.16
$37.14
$37.76
$35.42
$37.85
$31.82
Investment Operations
Net Investment Income1
.209
.540
.658
.620
.596
.576
Net Realized and Unrealized Gain (Loss) on Investments
.863
1.769
3.053
2.573
(.893)
7.593
Total from Investment Operations
1.072
2.309
3.711
3.193
(.297)
8.169
Distributions
Dividends from Net Investment Income
(.239)
(.577)
(.679)
(.629)
(.590)
(.574)
Distributions from Realized Capital Gains
(2.083)
(5.712)
(3.652)
(.224)
(1.543)
(1.565)
Total Distributions
(2.322)
(6.289)
(4.331)
(.853)
(2.133)
(2.139)
Net Asset Value, End of Period
$31.91
$33.16
$37.14
$37.76
$35.42
$37.85
Total Return2
4.08%
6.58%
10.20%
9.11%
-0.76%
25.66%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$35,481
$40,339
$50,424
$52,553
$53,452
$54,186
Ratio of Total Expenses to Average Net Assets3
0.19%4
0.20%4
0.22%5
0.29%5
0.30%5
0.27%
Ratio of Net Investment Income to Average Net Assets
1.34%
1.50%
1.68%
1.74%
1.68%
1.56%
Portfolio Turnover Rate
25%
40%
16%
9%
11%
15%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
Includes performance-based investment advisory fee increases (decreases) of (0.09%), (0.07%), (0.05%), 0.02%, 0.03%, and (0.00%).
4
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.19% and 0.20%, respectively.
5
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.22%, 0.29%, and 0.30%, respectively.
 
See accompanying Notes, which are an integral part of the Financial Statements.
6
Dividend Growth Fund
Notes to Financial Statements
Vanguard Dividend Growth Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund.
A.
The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund
consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund's pricing time but after the close of the securities' primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund's pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund's pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund's tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund's tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund's financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund's regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund's board of trustees and included in Management and Administrative expenses on the fund's Statement of Operations. Any borrowings under either facility bear interest at the higher of the effective federal funds rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the "Order") from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the "Interfund Lending Program"), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund's investment objective
7
Dividend Growth Fund
and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day's notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the six months ended July 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Premiums and discounts on debt securities are amortized and accreted, respectively, to interest income over the lives of the respective securities, except for premiums on certain callable debt securities that are amortized to the earliest call date. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
B.
Wellington Management Company LLP provides investment advisory services to the fund for a basic fee calculated at an annual percentage rate of
average net assets. The basic fee is subject to quarterly adjustments based on the fund's performance relative to the S&P U.S. Dividend Growers Index for the preceding three years. For the six months ended July 31, 2026, the investment advisory fee represented an effective annual basic basic rate of 0.13% of the fund's average net assets, before a net decrease of $15,674,000 (0.09%) based on performance.
C.
In accordance with the terms of a Funds' Service Agreement (the "FSA") between Vanguard and the fund, Vanguard furnishes to the fund
corporate management, administrative, marketing, and distribution services at Vanguard's cost of operations (as defined by the FSA). These costs of
operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At July 31, 2026, the fund had contributed to Vanguard capital in the amount of $763,000, representing less than 0.01% of the fund's net assets and 0.31% of Vanguard's capital received pursuant to the FSA. The fund's trustees and officers are also directors and employees, respectively, of Vanguard.
D.
The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have
agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund's management and administrative
expenses. For the six months ended July 31, 2026, these arrangements reduced the fund's expenses by $44,000 (an annual rate of less than 0.01% of average net assets).
E.
Various inputs may be used to determine the value of the fund's investments. These inputs are summarized in three broad levels for financial
statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in
those securities.
Level 1-Quoted prices in active markets for identical securities.
Level 2-Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3-Significant unobservable inputs (including the fund's own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund's investments as of July 31, 2026, based on the inputs used to value them: 
Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments 
Assets
Common Stocks
34,253,122
865,667
-
35,118,789
Temporary Cash Investments
26
402,100
-
402,126
Total
34,253,148
1,267,767
-
35,520,915
F.
As of July 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: 
Amount
($000)
Tax Cost
20,433,158
Gross Unrealized Appreciation
15,307,570
Gross Unrealized Depreciation
(219,813)
Net Unrealized Appreciation (Depreciation)
15,087,757
G.
During the six months ended July 31, 2026, the fund purchased $9,100,905,000 of investment securities and sold $14,633,924,000 of investment securities, other than temporary cash investments.
The fund purchased securities from and sold securities to other funds or accounts managed by its investment advisor or their affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the six months ended July 31, 2026, such purchases were $0 and sales were $8,924,000, resulting in net realized loss of $149,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
8
Dividend Growth Fund
H.
Capital shares issued and redeemed were:
 
Six Months
Ended
July 31, 2026
Year Ended
January 31,
2026
Shares
(000)
Shares
(000)
Issued
17,279
69,573
Issued in Lieu of Cash Distributions
83,196
189,599
Redeemed
(204,906)
(400,538)
Net Increase (Decrease) in Shares Outstanding
(104,431)
(141,366)
I.
Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory
conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse
impact on the value of the fund's investments and fund performance.
To the extent the fund's investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
J.
Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their
operating results regularly reviewed by a chief operating decision maker ("CODM"). The fund is considered a single segment. Vanguard's chief
executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund's chief financial officer
collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund's
daily operations. Through these committees, the CODM manages the fund's operations to achieve a single investment objective, as detailed in its
prospectus, through the execution of the fund's investment strategies. When assessing segment performance and making decisions about segment
resources, the CODM relies on the fund's portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the
information contained in the fund's financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying
financial statements.
K.
Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would
require recognition or disclosure in these financial statements.
Q572 092026
9
 
Financial Statements
For the six-months ended July 31, 2026
Vanguard Energy Opportunities Fund
(formerly Vanguard Energy Fund)
 
Contents 
Financial Statements
1
 
 
Energy Opportunities Fund
Financial Statements (unaudited)
Schedule of Investments
As of July 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund's Form N-PORT reports are available on the SEC's website at www.sec.gov. 
Shares
Market
Value•
($000)
Common Stocks (99.5%)
Brazil (1.1%)
 
Petroleo Brasileiro SA - Petrobras  
 8,559,325
   82,805
Canada (0.5%)
 
Cameco Corp.  
   453,660
   39,187
France (11.8%)
 
Engie SA (XPAR)
11,289,219
  351,897
 
TotalEnergies SE (TQEX)
 3,597,462
  317,154
 
TotalEnergies SE (XNYS) ADR
 2,202,526
  193,514
  
          
  862,565
Germany (2.2%)
 
E.ON SE  
 7,573,211
  163,152
India (1.7%)
 
Reliance Industries Ltd.
 5,458,905
   74,740
 
Power Grid Corp. of India Ltd.
17,220,012
   51,260
  
          
  126,000
Italy (4.0%)
 
Enel SpA
15,448,382
  174,465
 
Tenaris SA ADR
 1,720,815
   98,654
 
Tenaris SA
   681,309
   19,547
  
          
  292,666
Japan (1.1%)
 
Kansai Electric Power Co. Inc.  
 5,108,178
   77,361
Norway (1.4%)
 
Equinor ASA
 1,944,139
   79,808
 
Equinor ASA ADR
   622,430
   25,582
  
          
  105,390
Russia (0.0%)
*,1
LUKOIL PJSC ADR  
 1,423,477
       -
Spain (1.5%)
 
Iberdrola SA  
 4,437,206
  105,399
United Kingdom (11.3%)
 
Shell plc (XLON)
 8,086,763
  370,145
 
National Grid plc
12,784,719
  204,630
 
SSE plc
 5,389,181
  170,263
*
Glencore plc
11,089,583
   81,679
  
          
  826,717
United States (62.9%)
 
ExxonMobil Holdings Corp.
 4,196,279
  652,270
 
Chevron Corp.
 1,548,721
  304,835
 
Targa Resources Corp.
 1,120,381
  302,917
 
Shell plc ADR
 3,149,741
  289,713
 
Williams Cos. Inc.
 3,773,636
  269,966
 
Dominion Energy Inc.
 3,773,885
  261,040
 
Sempra
 2,916,432
  258,250
 
Devon Energy Corp.
 5,510,351
  248,682
 
Diamondback Energy Inc.
 1,209,971
  245,564
 
American Electric Power Co. Inc.
 1,754,930
  224,368
 
Duke Energy Corp.
 1,771,348
  222,180
 
Southern Co.
 2,316,559
  219,007
 
Marathon Petroleum Corp.
   674,008
  213,303
 
Phillips 66
   960,443
  203,307
 
NextEra Energy Inc.
 2,146,224
  186,550
 
Cheniere Energy Inc.
   576,887
  152,050
1
Energy Opportunities Fund
Shares
Market
Value•
($000)
 
Atmos Energy Corp.
   680,974
  117,659
 
Exelon Corp.
 2,515,096
  115,242
 
Constellation Energy Corp.
   194,178
   51,020
 
Vistra Corp.
   293,794
   43,537
 
CMS Energy Corp.
   188,376
   13,561
  
          
4,595,021
Total Common Stocks (Cost $4,699,425)
7,276,263
Temporary Cash Investments (0.5%)
Money Market Fund (0.0%)
2
Vanguard Market Liquidity Fund, 3.718% 
       596
       59
Face
Amount
($000)

Repurchase Agreement (0.5%)
 
NatWest Markets plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $36,611, collateralized by U.S. Treasury Obligations 3.500%, 10/31/2027, with a value of $37,332) 
    36,600
   36,600
Total Temporary Cash Investments (Cost $36,659)
36,659
Total Investments (100.0%) (Cost $4,736,084)
7,312,922
Other Assets and Liabilities-Net (0.0%)
(2,362)
Net Assets (100%)
7,310,560
Cost is in $000.
 
•
See Note A in Notes to Financial Statements.
*
Non-income-producing security.
1
Security value determined using significant unobservable inputs.
2
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
ADR-American Depositary Receipt.
 
See accompanying Notes, which are an integral part of the Financial Statements.
2
Energy Opportunities Fund
Statement of Assets and Liabilities
As of July 31, 2026
 
($000s, except shares and per-share amounts)
Amount
Assets
Investments in Securities, at Value
Unaffiliated Issuers (Cost $4,736,025)
7,312,863
Affiliated Issuers (Cost $59)
59
Total Investments in Securities
7,312,922
Investment in Vanguard
148
Cash
3
Foreign Currency, at Value (Cost $1,310)
1,324
Receivables for Accrued Income
7,222
Receivables for Capital Shares Issued
3,031
Other Assets
32
Total Assets
7,324,682
Liabilities
Payables to Investment Advisor
3,453
Payables for Capital Shares Redeemed
4,094
Payables to Vanguard
813
Deferred Foreign Capital Gains Taxes
5,762
Total Liabilities
14,122
Net Assets
7,310,560
At July 31, 2026, net assets consisted of:
Paid-in Capital
4,496,312
Total Distributable Earnings (Loss)
2,814,248
Net Assets
7,310,560
Investor Shares-Net Assets
Applicable to 32,627,892 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
1,939,692
Net Asset Value Per Share-Investor Shares
$59.45
Admiral™ Shares-Net Assets
Applicable to 48,137,874 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
5,370,868
Net Asset Value Per Share-Admiral Shares
$111.57
  See accompanying Notes, which are an integral part of the Financial Statements.
3
Energy Opportunities Fund
Statement of Operations
 
Six Months Ended
July 31, 2026
($000)
Investment Income
Income
Dividends1
128,115
Interest
1,045
Securities Lending-Net
11
Total Income
129,171
Expenses
Investment Advisory Fees-Note B
Basic Fee
5,420
Performance Adjustment
1,506
The Vanguard Group-Note C
Management and Administrative-Investor Shares
2,321
Management and Administrative-Admiral Shares
3,942
Marketing and Distribution-Investor Shares
63
Marketing and Distribution-Admiral Shares
103
Custodian Fees
43
Shareholders' Reports-Investor Shares
31
Shareholders' Reports-Admiral Shares
20
Trustees' Fees and Expenses
2
Other Expenses
198
Total Expenses
13,649
Expenses Paid Indirectly
(15
)
Net Expenses
13,634
Net Investment Income
115,537
Realized Net Gain (Loss)
Investment Securities Sold2,3
133,569
Foreign Currencies
(117
)
Realized Net Gain (Loss)
133,452
Change in Unrealized Appreciation (Depreciation)
Investment Securities2,4
689,305
Foreign Currencies
(205
)
Change in Unrealized Appreciation (Depreciation)
689,100
Net Increase (Decrease) in Net Assets Resulting from Operations
938,089
 
1
Dividends are net of foreign withholding taxes of $2,945.
2
Realized net gain (loss) and change in unrealized appreciation (depreciation) from an affiliated company of the fund were ($1) and less than $1, respectively. Purchases and sales are for temporary cash investment
purposes.
3
Realized gain (loss) is net of foreign capital gain taxes of $177.
4
The change in unrealized appreciation (depreciation) is net of the change in deferred foreign capital gains taxes of ($568).
  See accompanying Notes, which are an integral part of the Financial Statements.
4
Energy Opportunities Fund
Statement of Changes in Net Assets
 
Six Months Ended
July 31,
2026
Year Ended
January 31,
2026
($000)
($000)
Increase (Decrease) in Net Assets
Operations
Net Investment Income
115,537
205,123
Realized Net Gain (Loss)
133,452
320,986
Change in Unrealized Appreciation (Depreciation)
689,100
945,471
Net Increase (Decrease) in Net Assets Resulting from Operations
938,089
1,471,580
Distributions
Investor Shares
(68,132
)
(81,652
)
Admiral Shares
(159,215
)
(199,527
)
Total Distributions
(227,347
)
(281,179
)
Capital Share Transactions
Investor Shares
(214,782
)
(228,060
)
Admiral Shares
183,693
86,706
Net Increase (Decrease) from Capital Share Transactions
(31,089
)
(141,354
)
Total Increase (Decrease)
679,653
1,049,047
Net Assets
Beginning of Period
6,630,907
5,581,860
End of Period
7,310,560
6,630,907
  See accompanying Notes, which are an integral part of the Financial Statements.
5
Energy Opportunities Fund
Financial Highlights
 
  
Investor Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$53.66
$44.04
$45.21
$46.43
$41.64
$31.66
Investment Operations
Net Investment Income1
.908
1.646
1.771
1.878
2.099
1.364
Net Realized and Unrealized Gain (Loss) on Investments
6.704
10.310
5.270
.080
4.807
10.019
Total from Investment Operations
7.612
11.956
7.041
1.958
6.906
11.383
Distributions
Dividends from Net Investment Income
-
(1.689)
(1.685)
(1.952)
(2.116)
(1.403)
Distributions from Realized Capital Gains
(1.822)
(.647)
(6.526)
(1.226)
-
-
Total Distributions
(1.822)
(2.336)
(8.211)
(3.178)
(2.116)
(1.403)
Net Asset Value, End of Period
$59.45
$53.66
$44.04
$45.21
$46.43
$41.64
Total Return2
14.17%
27.60%
16.24%
4.00%
16.72%
36.33%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$1,940
$1,954
$1,815
$1,775
$1,950
$1,771
Ratio of Total Expenses to Average Net Assets3
0.44%4
0.45%4
0.45%5
0.44%5
0.46%5
0.41%
Ratio of Net Investment Income to Average Net Assets
3.13%
3.41%
3.62%
4.02%
4.70%
3.68%
Portfolio Turnover Rate
8%
19%
36%
29%
16%
14%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
Includes performance-based investment advisory fee increases (decreases) of 0.04%, 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
4
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.44% and 0.45%, respectively.
5
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.45%, 0.44% and 0.46% respectively.
 
See accompanying Notes, which are an integral part of the Financial Statements.
6
Energy Opportunities Fund
Financial Highlights
  
Admiral Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$100.66
$82.62
$84.83
$87.12
$78.12
$59.39
Investment Operations
Net Investment Income1
1.750
3.156
3.392
3.599
4.014
2.615
Net Realized and Unrealized Gain (Loss) on Investments
12.579
19.345
9.886
.145
9.026
18.794
Total from Investment Operations
14.329
22.501
13.278
3.744
13.040
21.409
Distributions
Dividends from Net Investment Income
-
(3.246)
(3.238)
(3.733)
(4.040)
(2.679)
Distributions from Realized Capital Gains
(3.419)
(1.215)
(12.250)
(2.301)
-
-
Total Distributions
(3.419)
(4.461)
(15.488)
(6.034)
(4.040)
(2.679)
Net Asset Value, End of Period
$111.57
$100.66
$82.62
$84.83
$87.12
$78.12
Total Return2
14.22%
27.70%
16.33%
4.09%
16.83%
36.43%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$5,371
$4,677
$3,767
$3,625
$4,176
$3,608
Ratio of Total Expenses to Average Net Assets3
0.36%4
0.37%4
0.37%5
0.36%5
0.38%5
0.33%
Ratio of Net Investment Income to Average Net Assets
3.22%
3.48%
3.69%
4.11%
4.78%
3.76%
Portfolio Turnover Rate
8%
19%
36%
29%
16%
14%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
Includes performance-based investment advisory fee increases (decreases) of 0.04%, 0.05%, 0.05%, 0.05%, 0.06%, and 0.02%.
4
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.36% and 0.37%, respectively.
5
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.36%, and 0.38% respectively.
 
See accompanying Notes, which are an integral part of the Financial Statements.
7
Energy Opportunities Fund
Notes to Financial Statements
Vanguard Energy Opportunities Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: Investor Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors.
In February 2026, the board of trustees approved changing the fund's name to Vanguard Energy Opportunities Fund to better reflect its existing investment strategy, which became effective in May 2026.
A.
The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund
consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund's pricing time but after the close of the securities' primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund's pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund's pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund's tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund's tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund's financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund's regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund's board of trustees and included in Management and
8
Energy Opportunities Fund
Administrative expenses on the fund's Statement of Operations. Any borrowings under either facility bear interest at the higher of the effective federal funds rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the "Order") from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the "Interfund Lending Program"), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund's investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day's notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the six months ended July 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Taxes on foreign dividends and capital gains have been provided for in accordance with the applicable countries' tax rules and rates. Foreign capital gains tax, if any, is accrued daily based upon applicable net unrealized gains. The fund has filed tax reclaims for previously withheld taxes on dividends earned in certain European Union countries. These filings are subject to various administrative and judicial proceedings within these countries. Amounts related to these reclaims are recorded when there are no significant uncertainties as to the ultimate resolution of proceedings, the likelihood of receipt of these reclaims, and the potential timing of payment. Such tax reclaims and related professional fees, if any, are included in dividend income and other expenses, respectively.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses) and shareholder reporting. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B.
Wellington Management Company LLP provides investment advisory services to the fund for a basic fee calculated at an annual percentage rate of average net assets. The basic fee is subject to quarterly adjustments based on the fund's performance relative to the MSCI ACWI Energy + Utilities Index for the preceding three years. For the six months ended July 31, 2026, the investment advisory fee paid represented an effective annual basic rate of 0.15% of the fund's average net assets, before a net increase of $1,506,000 (0.04%) based on performance.
C.
In accordance with the terms of a Funds' Service Agreement (the "FSA") between Vanguard and the fund, Vanguard furnishes to the fund
corporate management, administrative, marketing, and distribution services at Vanguard's cost of operations (as defined by the FSA). These costs of
operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At July 31, 2026, the fund had contributed to Vanguard capital in the amount of $148,000, representing less than 0.01% of the fund's net assets and 0.06% of Vanguard's capital received pursuant to the FSA. The fund's trustees and officers are also directors and employees, respectively, of Vanguard.
D.
The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have
agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund's management and administrative
expenses. For the six months ended July 31, 2026, these arrangements reduced the fund's expenses by $15,000 (an annual rate of less than 0.01% of average net assets).
E.
Various inputs may be used to determine the value of the fund's investments. These inputs are summarized in three broad levels for financial
statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in
those securities.
Level 1-Quoted prices in active markets for identical securities.
Level 2-Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3-Significant unobservable inputs (including the fund's own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund's investments as of July 31, 2026, based on the inputs used to value them: 
Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments 
Assets
Common Stocks-North and South America
4,717,013
-
-
4,717,013
Common Stocks-Other
317,750
2,241,500
-
2,559,250
Temporary Cash Investments
59
36,600
-
36,659
Total
5,034,822
2,278,100
-
7,312,922
9
Energy Opportunities Fund
F.
As of July 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: 
Amount
($000)
Tax Cost
4,740,542
Gross Unrealized Appreciation
2,666,654
Gross Unrealized Depreciation
(94,274)
Net Unrealized Appreciation (Depreciation)
2,572,380
G.
During the six months ended July 31, 2026, the fund purchased $567,188,000 of investment securities and sold $672,862,000 of investment securities, other than temporary cash investments.
H.
Capital share transactions for each class of shares were:
 
Six Months Ended
July 31, 2026
Year Ended
January 31, 2026
Amount
($000)
Shares
(000)
Amount
($000)
Shares
(000)
Investor Shares
Issued
230,111
3,946
245,956
5,073
Issued in Lieu of Cash Distributions
63,230
1,058
75,412
1,526
Redeemed
(508,123)
(8,800)
(549,428)
(11,379)
Net Increase (Decrease)-Investor Shares
(214,782)
(3,796)
(228,060)
(4,780)
Admiral Shares
Issued
597,929
5,506
598,680
6,585
Issued in Lieu of Cash Distributions
143,354
1,279
178,110
1,921
Redeemed
(557,590)
(5,106)
(690,084)
(7,644)
Net Increase (Decrease)-Admiral Shares
183,693
1,679
86,706
862
I.
Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory
conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse
impact on the value of the fund's investments and fund performance.
To the extent the fund's investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
J.
Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their
operating results regularly reviewed by a chief operating decision maker ("CODM"). The fund is considered a single segment. Vanguard's chief
executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund's chief financial officer
collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund's
daily operations. Through these committees, the CODM manages the fund's operations to achieve a single investment objective, as detailed in its
prospectus, through the execution of the fund's investment strategies. When assessing segment performance and making decisions about segment
resources, the CODM relies on the fund's portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the
information contained in the fund's financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying
financial statements.
K.
Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would
require recognition or disclosure in these financial statements.
Q512 092026
10
 
Financial Statements
For the six-months ended July 31, 2026
Vanguard Health Care Fund
 
Contents 
Financial Statements
1
 
 
Health Care Fund
Financial Statements (unaudited)
Schedule of Investments
As of July 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund's Form N-PORT reports are available on the SEC's website at www.sec.gov. 
Shares
Market
Value•
($000)
Common Stocks (97.8%)
Belgium (3.4%)
 
UCB SA
 2,513,004
   645,046
*
Argenx SE
   749,701
   642,117
  
          
 1,287,163
China (0.8%)
 
Jiangsu Hengrui Pharmaceuticals Co. Ltd. Class H
 9,939,973
    72,450
*
Zai Lab Ltd.
36,431,700
    66,385
*,1
GenFleet Therapeutics Shanghai Inc. Class H
18,491,938
    65,325
*
Duality Biotherapeutics Inc.
 2,771,377
    64,436
 
Shandong Weigao Group Medical Polymer Co. Ltd. Class H
77,092,000
    33,001
  
          
   301,597
Denmark (2.2%)
*
Genmab A/S
 1,278,865
   368,107
*
Ascendis Pharma A/S
 1,099,854
   268,265
 
Novo Nordisk A/S Class B
 4,140,939
   195,873
  
          
   832,245
Japan (4.7%)
 
Shionogi & Co. Ltd.
21,427,449
   387,436
 
Otsuka Holdings Co. Ltd.
 5,423,000
   376,028
 
Daiichi Sankyo Co. Ltd.
22,675,166
   366,465
 
Chugai Pharmaceutical Co. Ltd.
 8,264,744
   358,618
 
Eisai Co. Ltd.
 7,339,417
   220,644
 
M3 Inc.
 9,451,653
   105,888
  
          
 1,815,079
Netherlands (0.1%)
*
Pharvaris NV  
 1,165,414
    38,016
Switzerland (4.5%)
 
Novartis AG (Registered)
 4,658,547
   728,558
 
Galderma Group AG
 2,410,425
   524,536
 
Roche Holding AG
 1,029,839
   450,135
  
          
 1,703,229
United Kingdom (8.0%)
 
AstraZeneca plc
10,300,505
 1,752,222
 
GSK plc
44,047,406
 1,145,358
*,1
Immunocore Holdings plc ADR
 4,246,274
   143,567
  
          
 3,041,147
United States (74.1%)
 
Eli Lilly & Co.
 2,861,509
 3,287,416
 
Merck & Co. Inc.
15,657,269
 2,038,576
 
Johnson & Johnson
 7,191,566
 1,843,558
 
UnitedHealth Group Inc.
 3,730,515
 1,545,925
*
Edwards Lifesciences Corp.
11,357,910
   977,575
*
Intuitive Surgical Inc.
 2,725,449
   962,983
 
CVS Health Corp.
 9,210,092
   961,810
 
Cencora Inc.
 3,033,825
   944,551
*
Vertex Pharmaceuticals Inc.
 1,890,142
   901,787
 
AbbVie Inc.
 3,506,192
   879,844
 
Danaher Corp.
 4,275,150
   833,569
 
Regeneron Pharmaceuticals Inc.
 1,072,221
   817,708
 
Elevance Health Inc. (XNYS)
 1,858,361
   698,446
 
HCA Healthcare Inc.
 1,594,006
   641,731
*
Boston Scientific Corp.
13,314,532
   622,188
 
Agilent Technologies Inc.
 4,119,810
   570,058
*
Biogen Inc.
 2,745,486
   557,196
*
Alnylam Pharmaceuticals Inc.
 2,136,580
   439,110
*
Dexcom Inc.
 5,155,320
   430,211
 
Cardinal Health Inc.
 1,736,348
   399,412
1
Health Care Fund
Shares
Market
Value•
($000)
 
Abbott Laboratories
 3,719,444
   393,145
*
Centene Corp.
 6,149,030
   382,593
 
Amgen Inc.
   984,663
   379,253
*
Revolution Medicines Inc.
 1,988,729
   372,946
*
United Therapeutics Corp.
   719,385
   372,433
 
Medtronic plc
 4,228,128
   361,040
 
Stryker Corp.
 1,087,087
   354,064
*
Ionis Pharmaceuticals Inc.
 6,212,640
   321,628
*
Incyte Corp.
 2,386,201
   285,199
 
Thermo Fisher Scientific Inc.
   458,983
   263,594
*
Madrigal Pharmaceuticals Inc.
   563,117
   263,156
*
Cytokinetics Inc.
 3,341,262
   257,712
*
Bridgebio Pharma Inc.
 3,162,851
   253,313
 
STERIS plc
 1,100,961
   251,460
 
QIAGEN NV
 6,045,368
   250,278
*
CG oncology Inc.
 2,860,428
   203,634
 
Bristol-Myers Squibb Co.
 3,063,693
   200,090
*
PTC Therapeutics Inc.
 2,865,974
   194,915
*
Kymera Therapeutics Inc.
 1,796,469
   185,755
*
Scholar Rock Holding Corp.
 3,859,866
   182,552
*
Protagonist Therapeutics Inc.
 1,243,618
   169,928
*
Dianthus Therapeutics Inc.
 1,503,955
   160,803
*
Structure Therapeutics Inc. ADR
 3,278,237
   157,487
*
ICON plc
   933,744
   152,728
*
Option Care Health Inc.
 6,456,359
   148,690
*,1
HeartFlow Inc.
 5,795,579
   146,222
*
Celldex Therapeutics Inc.
 3,783,994
   144,019
 
Encompass Health Corp.
 1,252,498
   139,115
*
Moderna Inc.
 2,345,644
   128,588
*
Vaxcyte Inc.
 2,340,735
   126,587
*
Alignment Healthcare Inc.
 8,232,279
   122,249
*,1
Inspire Medical Systems Inc.
 2,093,826
   105,131
*
Arcus Biosciences Inc.
 3,445,827
    97,138
*,2
Zenas Biopharma Inc.
 2,937,055
    92,341
*
Immunome Inc.
 3,703,461
    84,291
*
Dyne Therapeutics Inc.
 2,808,140
    70,709
*
Stoke Therapeutics Inc.
 2,260,550
    65,239
*,2
Kailera Therapeutics Inc.
 2,191,928
    37,131
*,2
Aktis Oncology Inc.
 1,462,244
    32,272
*
Definium Therapeutics Inc.
   740,600
    32,231
  
          
28,295,313
Total Common Stocks (Cost $22,967,911)
37,313,789
Temporary Cash Investments (2.3%)
Money Market Fund (0.1%)
3,4
Vanguard Market Liquidity Fund, 3.718% 
   546,991
    54,694
Face
Amount
($000)

Repurchase Agreements (2.2%)
 
Bank of America Securities, LLC, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $15,005, collateralized by U.S. Treasury Obligations 1.750%-2.750%, 8/15/2041-8/15/2051, with a
value of $15,300) 
    15,000
    15,000
 
Bank of America Securities, LLC, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $18,906, collateralized by U.S. Government Agency Obligations 3.000%-5.084%,
11/1/2046-8/1/2056, with a value of $19,278) 
    18,900
    18,900
 
Bank of America Securities, LLC, 3.660%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $40,012, collateralized by U.S. Government Agency Obligations 2.000%-6.000%,
10/1/2026-7/1/2056, with a value of $40,800) 
    40,000
    40,000
 
Bank of Nova Scotia, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $63,319, collateralized by U.S. Treasury Obligations 0.000%-4.625%, 9/15/2026-8/15/2043, with a
value of $64,586) 
    63,300
    63,300
 
Barclays Capital Inc., 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $59,118, collateralized by U.S. Treasury Obligations 3.750%, 6/30/2030, with a value of $60,282) 
    59,100
    59,100
 
BNP Paribas Securities Corp., 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $82,425, collateralized by U.S. Treasury Obligations 1.125%-4.625%, 1/31/2027-11/15/2055, with
a value of $84,048) 
    82,400
    82,400
2
Health Care Fund
Face
Amount
($000)
Market
Value•
($000)
 
BNP Paribas Securities Corp., 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $60,618, collateralized by U.S. Government Agency Obligations 1.820%-7.000%,
3/1/2029-6/1/2056, with a value of $61,812) 
    60,600
    60,600
 
HSBC Bank USA, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $122,737, collateralized by U.S. Treasury Obligations 0.625%-4.250%, 7/31/2028-2/15/2043, with
a value of $125,154) 
   122,700
   122,700
 
HSBC Bank USA, 3.650%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $78,524, collateralized by U.S. Government Agency Obligations 2.000%-7.000%,
2/1/2034-6/1/2056, with a value of $80,070) 
    78,500
    78,500
 
JP Morgan Securities, LLC, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $55,017, collateralized by U.S. Treasury Obligations 0.000%, 10/1/2026, with a value of $56,100) 
    55,000
    55,000
 
Natixis SA, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $149,845, collateralized by U.S. Treasury and Government Agency Obligations 0.375%-6.250%,
1/31/2027-2/15/2055, with a value of $152,796) 
   149,800
   149,800
 
Nomura International plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $500, collateralized by U.S. Treasury Obligations 0.000%, 12/31/2026, with a value of $511) 
       500
       500
 
Nomura International plc, 3.640%, 8/3/2026
(Dated 7/31/2026, Repurchase Value $85,026, collateralized by U.S. Treasury Obligations 1.625%-4.625%, 3/31/2029-5/15/2031, with a
value of $86,700) 
    85,000
    85,000
  
          
   830,800
Total Temporary Cash Investments (Cost $885,493)
885,494
Total Investments (100.1%) (Cost $23,853,404)
38,199,283
Other Assets and Liabilities-Net (-0.1%)
(33,257)
Net Assets (100%)
38,166,026
Cost is in $000.
 
•
See Note A in Notes to Financial Statements.
*
Non-income-producing security.
1
Considered an affiliated company of the fund as the fund owns more than 5% of the outstanding voting securities of such company.
2
Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $53,202.
3
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
4
Collateral of $54,641 was received for securities on loan.
ADR-American Depositary Receipt.
 
See accompanying Notes, which are an integral part of the Financial Statements.
3
Health Care Fund
Statement of Assets and Liabilities
As of July 31, 2026
 
($000s, except shares and per-share amounts)
Amount
Assets
Investments in Securities, at Value1
Unaffiliated Issuers (Cost $23,201,321)
37,684,344
Affiliated Issuers (Cost $652,083)
514,939
Total Investments in Securities
38,199,283
Investment in Vanguard
831
Cash
48
Foreign Currency, at Value (Cost $2,775)
2,945
Receivables for Investment Securities Sold
102,251
Receivables for Accrued Income
114,621
Receivables for Capital Shares Issued
1,859
Other Assets
45
Total Assets
38,421,883
Liabilities
Payables for Investment Securities Purchased
174,903
Collateral for Securities on Loan
54,641
Payables to Investment Advisor
13,722
Payables for Capital Shares Redeemed
10,257
Payables to Vanguard
2,334
Total Liabilities
255,857
Net Assets
38,166,026
1 Includes $53,202 of securities on loan.
At July 31, 2026, net assets consisted of:
Paid-in Capital
21,283,210
Total Distributable Earnings (Loss)
16,882,816
Net Assets
38,166,026
Investor Shares-Net Assets
Applicable to 26,330,964 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
5,348,633
Net Asset Value Per Share-Investor Shares
$203.13
Admiral™ Shares-Net Assets
Applicable to 383,131,007 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
32,817,393
Net Asset Value Per Share-Admiral Shares
$85.66
  See accompanying Notes, which are an integral part of the Financial Statements.
4
Health Care Fund
Statement of Operations
 
Six Months Ended
July 31, 2026
($000)
Investment Income
Income
Dividends-Unaffiliated Issuers1
247,103
Interest-Unaffiliated Issuers
11,460
Securities Lending-Net
126
Total Income
258,689
Expenses
Investment Advisory Fees-Note B
Basic Fee
27,497
Performance Adjustment
1,498
The Vanguard Group-Note C
Management and Administrative-Investor Shares
4,878
Management and Administrative-Admiral Shares
20,143
Marketing and Distribution-Investor Shares
137
Marketing and Distribution-Admiral Shares
426
Custodian Fees
217
Shareholders' Reports-Investor Shares
60
Shareholders' Reports-Admiral Shares
63
Trustees' Fees and Expenses
9
Other Expenses
129
Total Expenses
55,057
Expenses Paid Indirectly
(10
)
Net Expenses
55,047
Net Investment Income
203,642
Realized Net Gain (Loss)
Investment Securities Sold-Unaffiliated Issuers
2,351,725
Investment Securities Sold-Affiliated Issuers
37,673
Foreign Currencies
(1,214
)
Realized Net Gain (Loss)
2,388,184
Change in Unrealized Appreciation (Depreciation)
Investment Securities-Unaffiliated Issuers
(1,615,938
)
Investment Securities-Affiliated Issuers
249,313
Foreign Currencies
(3,844
)
Change in Unrealized Appreciation (Depreciation)
(1,370,469
)
Net Increase (Decrease) in Net Assets Resulting from Operations
1,221,357
 
1
Dividends are net of foreign withholding taxes of $8,894.
  See accompanying Notes, which are an integral part of the Financial Statements.
5
Health Care Fund
Statement of Changes in Net Assets
 
Six Months Ended
July 31,
2026
Year Ended
January 31,
2026
($000)
($000)
Increase (Decrease) in Net Assets
Operations
Net Investment Income
203,642
450,050
Realized Net Gain (Loss)
2,388,184
2,133,114
Change in Unrealized Appreciation (Depreciation)
(1,370,469
)
1,258,174
Net Increase (Decrease) in Net Assets Resulting from Operations
1,221,357
3,841,338
Distributions
Investor Shares
(211,056
)
(261,878
)
Admiral Shares
(1,241,675
)
(1,510,572
)
Total Distributions
(1,452,731
)
(1,772,450
)
Capital Share Transactions
Investor Shares
(351,353
)
(964,124
)
Admiral Shares
(515,065
)
(3,747,907
)
Net Increase (Decrease) from Capital Share Transactions
(866,418
)
(4,712,031
)
Total Increase (Decrease)
(1,097,792
)
(2,643,143
)
Net Assets
Beginning of Period
39,263,818
41,906,961
End of Period
38,166,026
39,263,818
  See accompanying Notes, which are an integral part of the Financial Statements.
6
Health Care Fund
Financial Highlights
 
  
Investor Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$204.68
$192.16
$210.61
$212.59
$210.54
$218.60
Investment Operations
Net Investment Income1
1.019
2.125
1.733
1.789
1.654
1.869
Net Realized and Unrealized Gain (Loss) on Investments
5.089
19.194
3.617
11.217
11.988
8.949
Total from Investment Operations
6.108
21.319
5.350
13.006
13.642
10.818
Distributions
Dividends from Net Investment Income
(.136)
(2.117)
(1.809)
(1.751)
(1.659)
(1.951)
Distributions from Realized Capital Gains
(7.522)
(6.682)
(21.991)
(13.235)
(9.933)
(16.927)
Total Distributions
(7.658)
(8.799)
(23.800)
(14.986)
(11.592)
(18.878)
Net Asset Value, End of Period
$203.13
$204.68
$192.16
$210.61
$212.59
$210.54
Total Return2
3.35%
11.39%
2.96%
6.43%
6.57%
4.48%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$5,349
$5,749
$6,428
$7,297
$7,496
$7,493
Ratio of Total Expenses to Average Net Assets3
0.34%4
0.33%4
0.37%5
0.35%5
0.34%5
0.30%
Ratio of Net Investment Income to Average Net Assets
1.04%
1.15%
0.81%
0.86%
0.80%
0.82%
Portfolio Turnover Rate
24%
47%
29%
16%
19%
15%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
Includes performance-based investment advisory fee increases (decreases) of 0.01%, (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
4
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.34%, and 0.33% respectively.
5
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.37%, 0.35% and 0.34% respectively.
 
See accompanying Notes, which are an integral part of the Financial Statements.
7
Health Care Fund
Financial Highlights
  
Admiral Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$86.30
$81.02
$88.81
$89.64
$88.77
$92.17
Investment Operations
Net Investment Income1
.453
.940
.772
.796
.750
.830
Net Realized and Unrealized Gain (Loss) on Investments
2.150
8.099
1.523
4.738
5.052
3.780
Total from Investment Operations
2.603
9.039
2.295
5.534
5.802
4.610
Distributions
Dividends from Net Investment Income
(.072)
(.941)
(.810)
(.782)
(.743)
(.870)
Distributions from Realized Capital Gains
(3.171)
(2.818)
(9.275)
(5.582)
(4.189)
(7.140)
Total Distributions
(3.243)
(3.759)
(10.085)
(6.364)
(4.932)
(8.010)
Net Asset Value, End of Period
$85.66
$86.30
$81.02
$88.81
$89.64
$88.77
Total Return2
3.38%
11.46%
3.01%
6.48%
6.63%
4.53%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$32,817
$33,515
$35,479
$38,997
$39,981
$39,934
Ratio of Total Expenses to Average Net Assets3
0.28%4
0.27%4
0.32%5
0.30%5
0.29%5
0.25%
Ratio of Net Investment Income to Average Net Assets
1.09%
1.20%
0.85%
0.90%
0.86%
0.86%
Portfolio Turnover Rate
24%
47%
29%
16%
19%
15%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
Includes performance-based investment advisory fee increases (decreases) of 0.01%, (0.01%), 0.04%, 0.02%, 0.00%, and (0.04%).
4
The ratio of expenses to average net assets for the period net of reduction from broker commission abatement arrangements was 0.28%, and 0.27% respectively.
5
The ratio of expenses to average net assets for the period net of reduction from custody fee offset and broker commission abatement arrangements was 0.32%, 0.30%, and 0.29% respectively.
 
See accompanying Notes, which are an integral part of the Financial Statements.
8
Health Care Fund
Notes to Financial Statements
Vanguard Health Care Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: Investor Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors.
A.
The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund
consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund's pricing time but after the close of the securities' primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. These procedures include obtaining quotations from an independent pricing service, monitoring news to identify significant market- or security-specific events, and evaluating changes in the values of foreign market proxies (for example, ADRs, futures contracts, or exchange-traded funds), between the time the foreign markets close and the fund's pricing time. When fair-value pricing is employed, the prices of securities used by a fund to calculate its net asset value may differ from quoted or published prices for the same securities. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value. Other temporary cash investments are valued using the latest bid prices or using valuations based on a matrix system (which considers such factors as security prices, yields, maturities, and ratings), both as furnished by independent pricing services.
2. Foreign Currency: Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates obtained from an independent third party as of the fund's pricing time on the valuation date. Realized gains (losses) and unrealized appreciation (depreciation) on investment securities include the effects of changes in exchange rates since the securities were purchased, combined with the effects of changes in security prices. Fluctuations in the value of other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains (losses) until the assets or liabilities are settled in cash, at which time they are recorded as realized foreign currency gains (losses).
3. Repurchase Agreements: The fund enters into repurchase agreements with institutional counterparties. Securities pledged as collateral to the fund under repurchase agreements are held by a custodian bank until the agreements mature, and in the absence of a default, such collateral cannot be repledged, resold, or rehypothecated. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. The fund further mitigates its counterparty risk by entering into repurchase agreements only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master repurchase agreements with its counterparties. The master repurchase agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any repurchase agreements with that counterparty, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund. Such action may be subject to legal proceedings, which may delay or limit the disposition of collateral.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund's tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund's tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund's financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund's regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund's board of trustees and included in Management and Administrative expenses on the fund's Statement of Operations. Any borrowings under either facility bear interest at the higher of the effective federal funds rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
9
Health Care Fund
In accordance with an exemptive order (the "Order") from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the "Interfund Lending Program"), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund's investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day's notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the six months ended July 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund and is accrued daily. Premiums and discounts on debt securities are amortized and accreted, respectively, to interest income over the lives of the respective securities, except for premiums on certain callable debt securities that are amortized to the earliest call date. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Taxes on foreign dividends and capital gains have been provided for in accordance with the applicable countries' tax rules and rates. Deferred foreign capital gains tax, if any, is accrued daily based upon net unrealized gains. The fund has filed tax reclaims for previously withheld taxes on dividends earned in certain European Union countries. These filings are subject to various administrative and judicial proceedings within these countries. Amounts related to these reclaims are recorded when there are no significant uncertainties as to the ultimate resolution of proceedings, the likelihood of receipt of these reclaims, and the potential timing of payment. Such tax reclaims and related professional fees, if any, are included in dividend income and other expenses, respectively.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses) and shareholder reporting. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B.
Wellington Management Company LLP provides investment advisory services to the fund for a basic fee calculated at an annual percentage rate of
average net assets. The basic fee is subject to quarterly adjustments based on the fund's performance relative to the MSCI All Country World Health
Care Index for the preceding three years. For the six months ended July 31, 2026, the investment advisory fee represented an effective annual basic rate of 0.15% of the fund's average net assets, before a net increase of $1,498,000 (0.01%) based on performance.
C.
In accordance with the terms of a Funds' Service Agreement (the "FSA") between Vanguard and the fund, Vanguard furnishes to the fund
corporate management, administrative, marketing, and distribution services at Vanguard's cost of operations (as defined by the FSA). These costs of
operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At July 31, 2026, the fund had contributed to Vanguard capital in the amount of $831,000, representing less than 0.01% of the fund's net assets and 0.33% of Vanguard's capital received pursuant to the FSA. The fund's trustees and officers are also directors and employees, respectively, of Vanguard.
D.
The fund has asked its investment advisor to direct certain security trades, subject to obtaining the best price and execution, to brokers who have
agreed to rebate to the fund part of the commissions generated. Such rebates are used solely to reduce the fund's management and administrative
expenses. For the six months ended July 31, 2026, these arrangements reduced the fund's expenses by $10,000 (an annual rate of less than 0.01% of average net assets).
E.
Various inputs may be used to determine the value of the fund's investments. These inputs are summarized in three broad levels for financial
statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with investing in
those securities.
Level 1-Quoted prices in active markets for identical securities.
Level 2-Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3-Significant unobservable inputs (including the fund's own assumptions used to determine the fair value of investments). Any investments valued with significant unobservable inputs are noted on the Schedule of Investments.
The following table summarizes the market value of the fund's investments as of July 31, 2026, based on the inputs used to value them: 
Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments 
Assets
Common Stocks-North and South America
28,295,313
-
-
28,295,313
Common Stocks-Other
449,848
8,568,628
-
9,018,476
Temporary Cash Investments
54,694
830,800
-
885,494
Total
28,799,855
9,399,428
-
38,199,283
10
Health Care Fund
F.
As of July 31, 2026, gross unrealized appreciation and depreciation for investments based on cost for U.S. federal income tax purposes were as follows: 
Amount
($000)
Tax Cost
24,032,707
Gross Unrealized Appreciation
15,117,326
Gross Unrealized Depreciation
(950,750)
Net Unrealized Appreciation (Depreciation)
14,166,576
G.
During the six months ended July 31, 2026, the fund purchased $8,801,804,000 of investment securities and sold $10,795,063,000 of investment securities, other than temporary cash investments.
The fund purchased securities from and sold securities to other funds or accounts managed by its investment advisor or their affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the six months ended July 31, 2026, such purchases were $20,274,000 and sales were $0, resulting in net realized gain (loss) of $0; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
H.
Capital share transactions for each class of shares were:
 
Six Months Ended
July 31, 2026
Year Ended
January 31, 2026
Amount
($000)
Shares
(000)
Amount
($000)
Shares
(000)
Investor Shares
Issued
72,802
368
263,438
1,377
Issued in Lieu of Cash Distributions
198,557
1,074
246,441
1,274
Redeemed
(622,712)
(3,199)
(1,474,003)
(8,017)
Net Increase (Decrease)-Investor Shares
(351,353)
(1,757)
(964,124)
(5,366)
Admiral Shares
Issued
348,487
4,280
667,798
8,521
Issued in Lieu of Cash Distributions
1,071,689
13,755
1,309,382
16,039
Redeemed
(1,935,241)
(23,267)
(5,725,087)
(74,113)
Net Increase (Decrease)-Admiral Shares
(515,065)
(5,232)
(3,747,907)
(49,553)
I.
Certain of the fund's investments were in companies that were considered to be affiliated companies of the fund because the fund owned more
than 5% of the outstanding voting securities of the company or the issuer was another member of The Vanguard Group. Transactions during the
period in securities of these companies were as follows:
 
Current Period Transactions
Jan. 31,
2026
Market
Value
($000)
Purchases
at Cost
($000)
Proceeds
from
Securities
Sold
($000)
Realized
Net
Gain
(Loss)
($000)
Change in
Unrealized
App. (Dep.)
($000)
Income
($000)
Capital Gain
Distributions
Received
($000)
Jul. 31,
2026
Market
Value
($000)
Acadia Healthcare Co. Inc.
118,483
-
241,515
(141,271
)
264,303
-
-
-
Apellis Pharmaceuticals Inc.
172,343
18,957
350,318
171,666
(12,648
)
-
-
-
Celldex Therapeutics Inc.
117,212
2,428
36,000
9,127
51,252
-
-
NA1
GenFleet Therapeutics Shanghai Inc. Class H
NA2
60,436
-
-
(2,904
)
-
-
65,325
HeartFlow Inc.
NA2
116,431
17,559
(1,848
)
(18,205
)
-
-
146,222
Immunocore Holdings plc ADR
119,062
18,716
-
-
5,789
-
-
143,567
Inspire Medical Systems Inc.
NA2
60,500
-
-
(38,274
)
-
-
105,131
Vanguard Market Liquidity Fund
58,780
NA3
NA3
(1
)
-
-
-
54,694
Total
585,880
277,468
645,392
37,673
249,313
-
-
514,939
 
1
Not applicable-at July 31, 2026, the issuer was not an affiliated company of the fund.
2
Not applicable-at January 31, 2026, the issuer was not an affiliated company of the fund.
3
Not applicable-purchases and sales are for temporary cash investment purposes.
J.
Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory
conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse
impact on the value of the fund's investments and fund performance.
To the extent the fund's investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
11
Health Care Fund
K.
Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their
operating results regularly reviewed by a chief operating decision maker ("CODM"). The fund is considered a single segment. Vanguard's chief
executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund's chief financial officer
collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund's
daily operations. Through these committees, the CODM manages the fund's operations to achieve a single investment objective, as detailed in its
prospectus, through the execution of the fund's investment strategies. When assessing segment performance and making decisions about segment
resources, the CODM relies on the fund's portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the
information contained in the fund's financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying
financial statements.
L.
Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would
require recognition or disclosure in these financial statements.
Q522 092026
12
 
Financial Statements
For the six-months ended July 31, 2026
Vanguard Dividend Appreciation Index Fund
 
Contents 
Financial Statements
1
 
 
Dividend Appreciation Index Fund
Financial Statements (unaudited)
Schedule of Investments
As of July 31, 2026
The fund files its complete schedule of portfolio holdings with the Securities and Exchange Commission (SEC) for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The fund's Form N-PORT reports are available on the SEC's website at www.sec.gov. 
Shares
Market
Value•
($000)
Common Stocks (99.6%)
Consumer Discretionary (4.2%)
 
Home Depot Inc.
 5,635,483
  1,870,755
 
McDonald's Corp.
 4,020,007
  1,087,975
 
Starbucks Corp.
 6,448,365
    678,690
 
Lowe's Cos. Inc.
 3,168,810
    658,510
 
NIKE Inc. Class B
 6,786,699
    283,073
 
DR Horton Inc.
 1,492,167
    213,469
 
Williams-Sonoma Inc.
   666,181
    152,329
 
Tractor Supply Co.
 2,967,328
     91,305
 
Dick's Sporting Goods Inc.
   372,736
     73,023
 
Service Corp. International
   780,632
     67,283
 
Domino's Pizza Inc.
   173,140
     60,156
 
Lithia Motors Inc.
   129,037
     49,733
 
Pool Corp.
   181,450
     33,697
 
Churchill Downs Inc.
   374,632
     31,581
 
Brunswick Corp.
   367,639
     29,044
 
Graham Holdings Co. Class B
    18,918
     22,769
 
Thor Industries Inc.
   297,629
     22,313
 
Dillard's Inc. Class A
    17,106
     10,064
 
Shoe Station Group Inc.
   101,061
      1,536
  
          
  5,437,305
Consumer Staples (9.3%)
 
Walmart Inc.
24,804,699
  2,758,282
 
Costco Wholesale Corp.
 2,510,169
  2,389,405
 
Coca-Cola Co.
21,908,953
  1,919,005
 
Procter & Gamble Co.
13,175,110
  1,903,672
 
PepsiCo Inc.
 7,733,128
  1,079,235
 
Mondelez International Inc. Class A
 7,262,857
    452,549
 
Colgate-Palmolive Co.
 4,527,448
    413,356
 
Sysco Corp.
 2,705,553
    230,621
 
Archer-Daniels-Midland Co.
 2,726,900
    216,161
 
Casey's General Stores Inc.
   209,118
    182,142
 
Church & Dwight Co. Inc.
 1,340,643
    132,469
 
Kroger Co.
 2,209,425
    127,572
 
Constellation Brands Inc. Class A
   789,072
    102,761
 
Tyson Foods Inc. Class A
 1,596,232
     92,518
 
McCormick & Co. Inc.
 1,437,065
     73,147
 
Ingredion Inc.
   356,787
     35,486
 
Brown-Forman Corp. Class B
 1,020,870
     29,330
 
WD-40 Co.
    76,102
     17,286
 
Andersons Inc.
   190,829
     13,507
 
Marzetti Co.
   114,776
     12,266
 
Brown-Forman Corp. Class A
   246,899
      7,214
 
Oil-Dri Corp. of America
    57,966
      5,751
 
Tootsie Roll Industries Inc.
   114,541
      4,469
  
          
 12,198,204
Energy (3.3%)
 
ExxonMobil Holdings Corp.
23,451,892
  3,645,362
 
Phillips 66
 2,268,474
    480,191
 
Texas Pacific Land Corp.
   327,812
    131,970
 
DT Midstream Inc.
   577,186
     79,652
  
          
  4,337,175
Financials (21.8%)
 
JPMorgan Chase & Co. (XNYS)
15,160,531
  5,333,323
 
Visa Inc. Class A (XNYS)
 8,745,550
  3,202,008
 
Mastercard Inc. Class A
 4,565,250
  2,616,345
 
Bank of America Corp. (XNYS)
36,939,952
  2,288,430
 
Goldman Sachs Group Inc. (XNYS)
 1,587,953
  1,617,140
 
Morgan Stanley
 6,782,381
  1,427,149
1
Dividend Appreciation Index Fund
Shares
Market
Value•
($000)
 
Blackrock Inc.
   816,820
    890,652
 
Chubb Ltd.
 2,040,872
    715,693
 
S&P Global Inc.
 1,715,485
    706,660
 
Bank of New York Mellon Corp.
 3,883,487
    607,105
 
CME Group Inc.
 2,050,196
    549,022
 
PNC Financial Services Group Inc.
 2,193,847
    548,177
 
Marsh & McLennan Cos. Inc.
 2,725,977
    517,091
 
Intercontinental Exchange Inc.
 3,199,633
    487,880
 
Travelers Cos. Inc.
 1,203,132
    450,404
 
Aon plc Class A (XNYS)
 1,208,405
    435,690
 
Moody's Corp.
   850,062
    406,653
 
Allstate Corp.
 1,456,479
    384,627
 
Arthur J Gallagher & Co.
 1,453,523
    362,538
 
Aflac Inc.
 2,591,821
    330,405
 
MetLife Inc.
 3,058,044
    293,970
 
Fifth Third Bancorp
 5,127,894
    289,726
 
State Street Corp.
 1,565,937
    288,383
 
Ameriprise Financial Inc.
   508,629
    277,630
 
Nasdaq Inc.
 2,527,847
    238,098
 
MSCI Inc.
   411,900
    235,706
 
Hartford Insurance Group Inc.
 1,551,020
    220,105
 
Cboe Global Markets Inc.
   592,127
    183,696
 
Raymond James Financial Inc.
   932,874
    164,167
 
Cincinnati Financial Corp.
   875,211
    155,507
 
Principal Financial Group Inc.
 1,112,190
    126,456
 
W R Berkley Corp.
 1,664,001
    120,707
 
Brown & Brown Inc.
 1,649,263
    116,108
 
Reinsurance Group of America Inc.
   370,668
     87,793
 
Globe Life Inc.
   439,309
     80,064
 
Assurant Inc.
   280,342
     78,269
 
RenaissanceRe Holdings Ltd.
   241,217
     77,185
 
Unum Group
   831,683
     71,616
 
Evercore Inc. Class A
   218,860
     70,158
 
Jack Henry & Associates Inc.
   402,008
     61,925
 
Wintrust Financial Corp.
   381,626
     60,885
 
Cullen / Frost Bankers Inc.
   355,312
     59,103
 
UMB Financial Corp.
   404,099
     58,889
 
Southstate Bank Corp.
   552,625
     58,075
 
Zions Bancorp NA
   832,263
     58,009
 
Primerica Inc.
   176,436
     56,452
 
American Financial Group Inc.
   390,182
     55,297
 
Old Republic International Corp.
 1,267,785
     54,781
 
FactSet Research Systems Inc.
   206,121
     54,251
 
SEI Investments Co.
   517,183
     53,259
 
Prosperity Bancshares Inc.
   666,613
     49,909
 
Hanover Insurance Group Inc.
   197,954
     46,050
 
Commerce Bancshares Inc.
   767,095
     45,466
 
First American Financial Corp.
   576,542
     43,235
 
Houlihan Lokey Inc.
   306,771
     38,497
 
Erie Indemnity Co. Class A
   143,742
     34,791
 
Home BancShares Inc.
 1,059,885
     32,931
 
MarketAxess Holdings Inc.
   201,100
     32,638
 
Selective Insurance Group Inc.
   338,745
     32,110
 
RLI Corp.
   520,201
     31,857
 
CNO Financial Group Inc.
   528,197
     29,098
 
First Financial Bankshares Inc.
   737,806
     25,926
 
ServisFirst Bancshares Inc.
   284,568
     25,469
 
Morningstar Inc.
   124,816
     24,036
 
United Community Banks Inc.
   677,281
     24,003
 
International Bancshares Corp.
   306,121
     23,430
 
Independent Bank Corp. (XNGS)
   273,463
     22,924
 
Assured Guaranty Ltd.
   235,439
     19,475
 
Community Financial System Inc.
   297,416
     19,275
 
Towne Bank
   486,216
     18,432
 
BOK Financial Corp.
   120,354
     17,005
 
NBT Bancorp Inc.
   294,165
     15,488
 
First Merchants Corp.
   349,576
     15,081
 
Enterprise Financial Services Corp.
   206,927
     13,721
 
BancFirst Corp.
   117,777
     13,288
 
Stock Yards Bancorp Inc.
   155,250
     13,212
2
Dividend Appreciation Index Fund
Shares
Market
Value•
($000)
 
Horace Mann Educators Corp.
   228,394
     11,902
 
City Holding Co.
    79,812
     11,581
 
National Bank Holdings Corp. Class A
   253,337
     10,942
 
German American Bancorp Inc.
   212,453
     10,810
 
Nelnet Inc. Class A
    78,760
     10,701
 
TriCo Bancshares
   180,486
     10,385
 
1st Source Corp.
   102,098
      9,162
 
Lakeland Financial Corp.
   140,911
      8,828
 
Bank First Corp.
    57,458
      8,776
 
Westamerica BanCorp
   132,844
      7,991
 
First Mid Bancshares Inc.
   136,991
      7,136
 
Mercantile Bank Corp.
    97,713
      5,871
 
Republic Bancorp Inc. Class A
    54,402
      5,415
 
First Community Bankshares Inc.
   106,753
      5,094
 
Independent Bank Corp.
   116,599
      4,454
 
Capital City Bank Group Inc.
    78,306
      4,062
 
Southern Missouri Bancorp Inc.
    52,346
      4,052
 
Cass Information Systems Inc.
    64,752
      3,621
 
Civista Bancshares Inc.
   117,595
      3,417
 
Northrim BanCorp Inc.
   125,912
      3,338
 
First Business Financial Services Inc.
    47,305
      3,321
 
Home Bancorp Inc.
    39,080
      2,788
 
Unity Bancorp Inc.
    37,513
      2,209
 
Investar Holding Corp.
    68,648
      2,068
  
          
 28,548,533
Health Care (17.7%)
 
Eli Lilly & Co.
 4,475,796
  5,141,974
 
Johnson & Johnson
13,619,903
  3,491,462
 
AbbVie Inc.
 9,996,424
  2,508,503
 
UnitedHealth Group Inc.
 5,138,234
  2,129,284
 
Merck & Co. Inc.
13,974,148
  1,819,434
 
Amgen Inc.
 3,053,644
  1,176,142
 
Abbott Laboratories
 9,855,078
  1,041,682
 
Gilead Sciences Inc.
 7,024,740
    914,691
 
Danaher Corp.
 3,564,034
    694,915
 
Stryker Corp.
 1,952,131
    635,809
 
Medtronic plc
 7,264,159
    620,287
 
McKesson Corp.
   680,107
    582,301
 
Elevance Health Inc. (XNYS)
 1,201,951
    451,741
 
Cencora Inc.
 1,100,813
    342,727
 
Cardinal Health Inc.
 1,325,132
    304,820
 
Becton Dickinson & Co.
 1,558,991
    258,200
 
Agilent Technologies Inc.
 1,598,947
    221,246
 
Zoetis Inc.
 2,371,968
    183,329
 
ResMed Inc.
   820,726
    173,157
 
Quest Diagnostics Inc.
   626,318
    145,938
 
West Pharmaceutical Services Inc.
   399,720
    136,289
 
STERIS plc
   554,901
    126,739
 
Ensign Group Inc.
   327,932
     58,424
 
Chemed Corp.
    75,100
     39,972
 
National HealthCare Corp.
    70,684
     15,977
 
LeMaitre Vascular Inc.
   118,907
     12,048
  
          
 23,227,091
Industrials (11.9%)
 
Caterpillar Inc. (XNYS)
 2,606,004
  2,123,398
 
Union Pacific Corp.
 3,359,190
    981,320
 
Eaton Corp. plc
 2,196,975
    912,184
 
Lockheed Martin Corp.
 1,147,972
    668,969
 
Automatic Data Processing Inc.
 2,261,663
    602,643
 
General Dynamics Corp.
 1,436,113
    550,634
 
CSX Corp.
10,513,241
    529,867
 
Cummins Inc.
   780,738
    495,144
 
Emerson Electric Co.
 3,169,015
    474,782
 
Waste Management Inc.
 2,090,338
    473,566
 
Honeywell International Inc.
 1,792,588
    435,689
 
Illinois Tool Works Inc.
 1,481,291
    425,056
 
Northrop Grumman Corp.
   755,404
    409,792
 
Cintas Corp.
 1,924,123
    393,733
*
Honeywell Aerospace Inc.
 1,792,588
    370,600
3
Dividend Appreciation Index Fund
Shares
Market
Value•
($000)
 
Comfort Systems USA Inc.
   198,842
    343,935
 
WW Grainger Inc.
   245,756
    339,689
 
Fastenal Co.
 6,495,538
    309,902
 
Rockwell Automation Inc.
   629,584
    302,251
 
L3Harris Technologies Inc.
 1,054,046
    292,034
 
Republic Services Inc.
 1,131,494
    238,236
 
Sunbelt Rentals Holdings Inc.
 2,321,210
    166,941
 
Xylem Inc.
 1,344,847
    157,307
 
Dover Corp.
   761,907
    155,901
 
Hubbell Inc.
   298,981
    141,284
 
Veralto Corp.
 1,389,581
    130,857
 
Expeditors International of Washington Inc.
   740,010
    124,240
 
Snap-on Inc.
   293,089
    120,287
 
RB Global Inc. (XTSE)
 1,054,076
    115,674
 
JB Hunt Transport Services Inc.
   421,496
    114,542
 
HEICO Corp. Class A
   439,066
    112,963
 
Broadridge Financial Solutions Inc.
   654,383
    100,742
 
ITT Inc.
   505,819
     99,130
 
CH Robinson Worldwide Inc.
   666,913
     98,523
 
IDEX Corp.
   418,772
     96,506
 
Nordson Corp.
   299,846
     89,288
 
BWX Technologies Inc.
   518,356
     87,447
 
Carlisle Cos. Inc.
   228,413
     82,210
 
Masco Corp.
 1,141,390
     81,587
1
HEICO Corp.
   227,851
     81,197
 
Lincoln Electric Holdings Inc.
   309,980
     81,001
 
Allegion plc
   486,215
     76,530
 
Graco Inc.
   939,038
     74,541
 
Lennox International Inc.
   179,173
     74,514
 
Huntington Ingalls Industries Inc.
   222,944
     72,780
 
Applied Industrial Technologies Inc.
   209,124
     72,192
 
Owens Corning
   455,622
     63,286
 
Donaldson Co. Inc.
   655,274
     61,753
 
Watsco Inc.
   198,052
     61,258
 
Pentair plc
   914,357
     59,836
 
Advanced Drainage Systems Inc.
   405,477
     56,150
 
Ryder System Inc.
   218,912
     56,133
 
Watts Water Technologies Inc. Class A
   155,452
     53,754
 
Toro Co.
   548,441
     50,385
 
Oshkosh Corp.
   352,777
     50,239
 
Timken Co.
   357,809
     49,217
 
Tetra Tech Inc.
 1,468,390
     48,692
 
Booz Allen Hamilton Holding Corp.
   682,309
     47,571
 
Simpson Manufacturing Co. Inc.
   232,758
     43,698
 
MSA Safety Inc.
   205,312
     39,065
 
A O Smith Corp.
   633,488
     38,092
 
Enpro Inc.
   119,531
     37,523
 
GATX Corp.
   200,857
     35,927
*
Mobility Global Inc.
 1,715,482
     34,962
 
Matson Inc.
   171,227
     34,689
 
Landstar System Inc.
   191,967
     33,550
 
UFP Industries Inc.
   319,581
     27,720
 
Brady Corp. Class A
   247,220
     23,305
 
Franklin Electric Co. Inc.
   215,013
     22,516
 
Mueller Water Products Inc. Class A
   885,430
     22,348
 
Kadant Inc.
    66,821
     20,547
 
Standex International Corp.
    68,557
     20,327
 
Griffon Corp.
   218,035
     18,788
 
Exponent Inc.
   274,562
     18,355
 
HNI Corp.
   394,990
     17,779
 
McGrath RentCorp.
   138,933
     15,998
 
ABM Industries Inc.
   331,071
     15,862
 
Worthington Enterprises Inc.
   175,507
      9,865
 
Alamo Group Inc.
    61,255
      9,744
 
Gorman-Rupp Co.
   118,006
      9,581
 
Tennant Co.
    96,373
      8,098
 
Lindsay Corp.
    58,807
      6,517
 
Apogee Enterprises Inc.
   120,061
      4,754
  
          
 15,509,492
4
Dividend Appreciation Index Fund
Shares
Market
Value•
($000)
Information Technology (25.3%)
 
Broadcom Inc.
15,566,653
  6,059,787
 
Apple Inc.
18,862,838
  5,826,919
 
Microsoft Corp.
12,220,245
  5,678,992
 
Cisco Systems Inc.
22,348,281
  2,592,177
 
Lam Research Corp.
 7,075,661
  2,073,310
 
Texas Instruments Inc.
 5,149,253
  1,419,855
 
KLA Corp.
 7,390,866
  1,351,198
 
Oracle Corp.
 9,600,785
  1,246,854
 
International Business Machines Corp.
 5,317,817
  1,189,330
 
Amphenol Corp. Class A
 6,960,596
  1,118,568
 
Analog Devices Inc.
 2,762,229
  1,014,871
 
QUALCOMM Inc.
 5,963,470
    880,268
 
Accenture plc Class A
 3,473,634
    576,345
 
Intuit Inc.
 1,564,701
    494,555
 
Motorola Solutions Inc.
   939,196
    409,255
 
TE Connectivity plc
 1,651,525
    339,702
 
Microchip Technology Inc.
 3,061,711
    227,455
 
Roper Technologies Inc.
   570,981
    223,807
 
CDW Corp.
   722,818
    106,840
 
Littelfuse Inc.
   143,088
     63,263
 
Cognex Corp.
   941,590
     61,429
 
Avnet Inc.
   464,084
     41,229
 
Amdocs Ltd.
   608,646
     33,914
 
Badger Meter Inc.
   165,165
     22,190
 
Dolby Laboratories Inc. Class A
   341,534
     20,086
 
Power Integrations Inc.
   315,298
     19,142
  
          
 33,091,341
Materials (3.2%)
 
Linde plc
 2,615,941
  1,251,414
 
Sherwin-Williams Co.
 1,297,768
    442,344
 
Ecolab Inc.
 1,433,122
    397,878
 
Air Products & Chemicals Inc.
 1,259,923
    371,539
 
Nucor Corp.
 1,288,546
    331,530
 
Vulcan Materials Co.
   734,152
    197,171
 
Steel Dynamics Inc.
   766,991
    192,714
 
Martin Marietta Materials Inc.
   339,743
    178,413
 
PPG Industries Inc.
 1,261,170
    139,385
 
Reliance Inc.
   288,829
    117,294
 
Royal Gold Inc.
   460,965
     91,432
 
Albemarle Corp.
   667,262
     78,497
 
RPM International Inc.
   722,111
     77,316
 
Avery Dennison Corp.
   432,775
     73,455
 
Solstice Advanced Materials Inc.
   898,510
     54,063
 
AptarGroup Inc.
   361,094
     48,372
 
Balchem Corp.
   181,797
     30,461
 
Cabot Corp.
   292,091
     25,710
 
Materion Corp.
   117,694
     24,815
 
Silgan Holdings Inc.
   496,353
     19,844
 
Avient Corp.
   519,005
     18,850
 
HB Fuller Co.
   308,371
     17,053
 
Hawkins Inc.
   118,034
     15,112
 
Westlake Corp.
   188,422
     13,284
 
Quaker Chemical Corp.
    77,600
     12,456
 
Innospec Inc.
   139,314
     11,978
 
Stepan Co.
   122,050
      7,828
  
          
  4,240,208
Utilities (2.9%)
 
NextEra Energy Inc.
11,798,735
  1,025,546
 
American Electric Power Co. Inc.
 3,078,512
    393,588
 
Sempra
 3,698,536
    327,505
 
Entergy Corp.
 2,590,686
    278,810
 
Xcel Energy Inc.
 3,532,066
    276,208
 
Public Service Enterprise Group Inc.
 2,819,470
    216,197
 
Ameren Corp.
 1,565,855
    171,633
 
DTE Energy Co.
 1,177,011
    166,983
 
Atmos Energy Corp.
   944,417
    163,176
 
American Water Works Co. Inc.
 1,104,881
    148,242
 
CMS Energy Corp.
 1,747,845
    125,827
5
Dividend Appreciation Index Fund
Shares
Market
Value•
($000)
 
NiSource Inc.
 2,712,618
    120,522
 
Alliant Energy Corp.
 1,461,303
    103,431
 
Essential Utilities Inc.
 1,604,755
     63,949
 
IDACORP Inc.
   313,490
     44,801
 
National Fuel Gas Co.
   537,705
     44,258
 
TXNM Energy Inc.
   563,742
     32,652
 
Otter Tail Corp.
   237,579
     21,007
 
American States Water Co.
   221,795
     18,995
 
Chesapeake Utilities Corp.
   135,851
     18,038
 
MGE Energy Inc.
   213,626
     16,990
 
California Water Service Group
   338,733
     16,974
 
H2O America
   222,451
     13,643
 
Middlesex Water Co.
   105,361
      6,037
 
York Water Co.
    91,703
      2,840
  
          
  3,817,852
Total Common Stocks (Cost $77,778,461)
130,407,201
Temporary Cash Investments (0.3%)
Money Market Fund (0.3%)
2,3
Vanguard Market Liquidity Fund, 3.718% (Cost $394,859)
 3,949,257
           394,886
Total Investments (99.9%) (Cost $78,173,320)
130,802,087
Other Assets and Liabilities-Net (0.1%)
97,778
Net Assets (100%)
130,899,865
Cost is in $000.
 
•
See Note A in Notes to Financial Statements.
*
Non-income-producing security.
1
Includes partial security positions on loan to broker-dealers. The total value of securities on loan is $7,721.
2
Affiliated money market fund available only to Vanguard funds and certain trusts and accounts managed by Vanguard. Rate shown is the 7-day yield.
3
Collateral of $7,892 was received for securities on loan.
  Derivative Financial Instruments Outstanding as of Period End  
Futures Contracts
($000)
 
Expiration
Number of
Long (Short)
Contracts
Notional
Amount
Value and
Unrealized
Appreciation
(Depreciation)
Long Futures Contracts
E-mini S&P 500 Index
September 2026
262
98,502
(547)
 
Over-the-Counter Total Return Swaps
Reference Entity
Termination
Date
Counterparty
Notional
Amount
($000)
Floating
Interest Rate
Received
(Paid)1
(%)
Value and
Unrealized
Appreciation
($000)
Value and
Unrealized
(Depreciation)
($000)
Elevance Health Inc.
2/1/2027
CITNA
10,221
(4.130
)
-
(186)
Goldman Sachs Group Inc.
8/31/2027
BANA
85,092
(4.445
)
-
(2,486)
Kroger Co.
2/1/2027
GSI
56,560
(3.630
)
1,089
-
Raymond James Financial Inc.
2/1/2027
CITNA
8,143
(4.183
)
375
-
Visa Inc. Class A
8/31/2026
BANA
233,832
(3.620
)
2,181
-
3,645
(2,672)
 
1
Based on Overnight Bank Funding Rate as of the most recent reset date. Floating interest payment received/(paid) monthly.
BANA-Bank of America, N.A.
CITNA-Citibank, N.A.
GSI-Goldman Sachs International.
At July 31, 2026, the counterparties had deposited in segregated accounts securities with a value of $1,356 and cash of $440 in connection with open over-the-counter swap contracts.
 
See accompanying Notes, which are an integral part of the Financial Statements.
6
Dividend Appreciation Index Fund
Statement of Assets and Liabilities
As of July 31, 2026
 
($000s, except shares and per-share amounts)
Amount
Assets
Investments in Securities, at Value1
Unaffiliated Issuers (Cost $77,778,461)
130,407,201
Affiliated Issuers (Cost $394,859)
394,886
Total Investments in Securities
130,802,087
Investment in Vanguard
2,771
Cash
73
Cash Collateral Pledged-Futures Contracts
5,580
Receivables for Accrued Income
101,592
Receivables for Capital Shares Issued
4,947
Variation Margin Receivable-Futures Contracts
521
Unrealized Appreciation-Over-the-Counter Swap Contracts
3,645
Other Assets
20
Total Assets
130,921,236
Liabilities
Payables for Investment Securities Purchased
1,771
Collateral for Securities on Loan
7,892
Payables for Capital Shares Redeemed
6,492
Payables to Vanguard
2,544
Unrealized Depreciation-Over-the-Counter Swap Contracts
2,672
Total Liabilities
21,371
Net Assets
130,899,865
1 Includes $7,721 of securities on loan.
At July 31, 2026, net assets consisted of:
Paid-in Capital
80,311,266
Total Distributable Earnings (Loss)
50,588,599
Net Assets
130,899,865
ETF Shares-Net Assets
Applicable to 465,695,866 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
111,359,571
Net Asset Value Per Share-ETF Shares
$239.13
Admiral™ Shares-Net Assets
Applicable to 301,114,889 outstanding $.001 par value shares of
beneficial interest (unlimited authorization)
19,540,294
Net Asset Value Per Share-Admiral Shares
$64.89
  See accompanying Notes, which are an integral part of the Financial Statements.
7
Dividend Appreciation Index Fund
Statement of Operations
 
Six Months Ended
July 31, 2026
($000)
Investment Income
Income
Dividends1
1,027,476
Interest2
12,519
Securities Lending-Net
12
Total Income
1,040,007
Expenses
The Vanguard Group-Note C
Investment Advisory Services
348
Management and Administrative-ETF Shares
18,097
Management and Administrative-Admiral Shares
5,946
Marketing and Distribution-ETF Shares
1,526
Marketing and Distribution-Admiral Shares
398
Custodian Fees
184
Shareholders' Reports-ETF Shares
812
Shareholders' Reports-Admiral Shares
105
Trustees' Fees and Expenses
30
Other Expenses
72
Total Expenses
27,518
Net Investment Income
1,012,489
Realized Net Gain (Loss)
Investment Securities Sold2,3
2,286,712
Futures Contracts
2,140
Swap Contracts
45,788
Realized Net Gain (Loss)
2,334,640
Change in Unrealized Appreciation (Depreciation)
Investment Securities2
5,866,769
Futures Contracts
(1,218
)
Swap Contracts
1,519
Change in Unrealized Appreciation (Depreciation)
5,867,070
Net Increase (Decrease) in Net Assets Resulting from Operations
9,214,199
 
1
Dividends are net of foreign withholding taxes of $96.
2
Interest income, realized net gain (loss), and change in unrealized appreciation (depreciation) from an affiliated company of the fund were $12,313, ($55), and ($23), respectively. Purchases and sales are for temporary
cash investment purposes.
3
Includes $2,800,484 of net gain (loss) resulting from in-kind redemptions.
  See accompanying Notes, which are an integral part of the Financial Statements.
8
Dividend Appreciation Index Fund
Statement of Changes in Net Assets
 
Six Months Ended
July 31,
2026
Year Ended
January 31,
2026
($000)
($000)
Increase (Decrease) in Net Assets
Operations
Net Investment Income
1,012,489
1,897,675
Realized Net Gain (Loss)
2,334,640
2,891,280
Change in Unrealized Appreciation (Depreciation)
5,867,070
8,903,547
Net Increase (Decrease) in Net Assets Resulting from Operations
9,214,199
13,692,502
Distributions
ETF Shares
(848,825
)
(1,611,638
)
Admiral Shares
(147,622
)
(284,573
)
Total Distributions
(996,447
)
(1,896,211
)
Capital Share Transactions
ETF Shares
1,302,849
3,637,560
Admiral Shares
(134,296
)
352,495
Net Increase (Decrease) from Capital Share Transactions
1,168,553
3,990,055
Total Increase (Decrease)
9,386,305
15,786,346
Net Assets
Beginning of Period
121,513,560
105,727,214
End of Period
130,899,865
121,513,560
  See accompanying Notes, which are an integral part of the Financial Statements.
9
Dividend Appreciation Index Fund
Financial Highlights
 
  
ETF Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$224.01
$202.26
$172.53
$156.26
$162.69
$137.11
Investment Operations
Net Investment Income1
1.863
3.560
3.381
3.185
2.982
2.736
Net Realized and Unrealized Gain (Loss) on Investments
15.089
21.748
29.728
16.293
(6.439)
25.504
Total from Investment Operations
16.952
25.308
33.109
19.478
(3.457)
28.240
Distributions
Dividends from Net Investment Income
(1.832)
(3.558)
(3.379)
(3.208)
(2.973)
(2.660)
Distributions from Realized Capital Gains
-
-
-
-
-
-
Total Distributions
(1.832)
(3.558)
(3.379)
(3.208)
(2.973)
(2.660)
Net Asset Value, End of Period
$239.13
$224.01
$202.26
$172.53
$156.26
$162.69
Total Return
7.63%
12.66%
19.34%
12.66%
-2.02%
20.71%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$111,360
$103,085
$89,405
$73,991
$66,062
$65,589
Ratio of Total Expenses to Average Net Assets
0.04%
0.05%
0.06%2
0.06%2
0.06%2
0.06%
Ratio of Net Investment Income to Average Net Assets
1.64%
1.72%
1.78%
1.99%
1.96%
1.74%
Portfolio Turnover Rate3
4%
8%
11%
13%
12%
26%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.06%.
3
Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund's capital shares, including ETF Creation Units.
 
See accompanying Notes, which are an integral part of the Financial Statements.
10
Dividend Appreciation Index Fund
Financial Highlights
  
Admiral Shares
For a Share Outstanding
Throughout Each Period 
Six Months
Ended
July 31,
2026
Year Ended January 31,
2026
2025
2024
2023
2022
Net Asset Value, Beginning of Period
$60.79
$54.89
$46.82
$42.41
$44.15
$37.21
Investment Operations
Net Investment Income1
.497
.955
.907
.856
.801
.734
Net Realized and Unrealized Gain (Loss) on Investments
4.091
5.900
8.070
4.416
(1.743)
6.920
Total from Investment Operations
4.588
6.855
8.977
5.272
(.942)
7.654
Distributions
Dividends from Net Investment Income
(.488)
(.955)
(.907)
(.862)
(.798)
(.714)
Distributions from Realized Capital Gains
-
-
-
-
-
-
Total Distributions
(.488)
(.955)
(.907)
(.862)
(.798)
(.714)
Net Asset Value, End of Period
$64.89
$60.79
$54.89
$46.82
$42.41
$44.15
Total Return2
7.61%
12.63%
19.32%
12.64%
-2.02%
20.67%
Ratios/Supplemental Data
Net Assets, End of Period (Millions)
$19,540
$18,428
$16,322
$13,962
$12,471
$12,903
Ratio of Total Expenses to Average Net Assets
0.07%
0.07%
0.08%3
0.08%3
0.08%3
0.08%
Ratio of Net Investment Income to Average Net Assets
1.61%
1.70%
1.77%
1.97%
1.94%
1.72%
Portfolio Turnover Rate4
4%
8%
11%
13%
12%
26%
The expense ratio and net investment income ratio for the current period have been annualized.
 
1
Calculated based on average shares outstanding.
2
Total returns do not include account service fees that may have applied in the periods shown. Fund prospectuses provide information about any applicable account service fees.
3
The ratio of expenses to average net assets for the period net of reduction from custody fee offset arrangements was 0.08%.
4
Excludes the value of portfolio securities received or delivered as a result of in-kind purchases or redemptions of the fund's capital shares, including ETF Creation Units.
 
See accompanying Notes, which are an integral part of the Financial Statements.
11
Dividend Appreciation Index Fund
Notes to Financial Statements
Vanguard Dividend Appreciation Index Fund is registered under the Investment Company Act of 1940 as an open-end investment company, or mutual fund. The fund offers two classes of shares: ETF Shares and Admiral Shares. Each of the share classes has different eligibility and minimum purchase requirements, and is designed for different types of investors. ETF Shares are listed for trading on NYSE Arca; they can be purchased and sold through a broker.
A.
The following significant accounting policies conform to generally accepted accounting principles for U.S. investment companies. The fund
consistently follows such policies in preparing its financial statements.
1. Security Valuation: Securities are valued as of the close of trading on the New York Stock Exchange (generally 4 p.m., Eastern time) on the valuation date. Equity securities are valued at the latest quoted sales prices or official closing prices taken from the primary market in which each security trades; such securities not traded on the valuation date are valued at the mean of the latest quoted bid and asked prices. Securities for which market quotations are not readily available, or whose values have been affected by events occurring before the fund's pricing time but after the close of the securities' primary markets, are valued by methods deemed by the valuation designee to represent fair value and subject to oversight by the board of trustees. Investments in Vanguard Market Liquidity Fund are valued at that fund's net asset value.
2. Futures Contracts: The fund uses index futures contracts to a limited extent, with the objectives of maintaining full exposure to the stock market, maintaining liquidity, and minimizing transaction costs. The fund may purchase futures contracts to immediately invest incoming cash in the market, or sell futures in response to cash outflows, thereby simulating a fully invested position in the underlying index while maintaining a cash balance for liquidity. The primary risks associated with the use of futures contracts are imperfect correlation between changes in market values of stocks held by the fund and the prices of futures contracts, and the possibility of an illiquid market. Counterparty risk involving futures is mitigated because a regulated clearinghouse is the counterparty instead of the clearing broker. To further mitigate counterparty risk, the fund trades futures contracts on an exchange, monitors the financial strength of its clearing brokers and clearinghouse, and has entered into clearing agreements with its clearing brokers. The clearinghouse imposes initial margin requirements to secure the fund's performance and requires daily settlement of variation margin representing changes in the market value of each contract. Any securities pledged as initial margin for open contracts are noted in the Schedule of Investments.
Futures contracts are valued at their quoted daily settlement prices. The notional amounts of the contracts are not recorded in the Statement of Assets and Liabilities. Fluctuations in the value of the contracts are recorded in the Statement of Assets and Liabilities as an asset (liability) and in the Statement of Operations as unrealized appreciation (depreciation) until the contracts are closed, when they are recorded as realized gains (losses) on futures contracts.
During the six months ended July 31, 2026, the fund's average investments in long and short futures contracts represented less than 1% and 0% of net assets, respectively, based on the average of the notional amounts at each quarter-end during the period.
3.  Swap Contracts: The fund has entered into equity swap contracts to earn the total return on selected reference stocks or indexes in the fund's target index. Under the terms of the swaps, the fund receives the total return on the referenced stock (i.e., receiving the increase or paying the decrease in value of the selected reference stock and receiving the equivalent of any dividends in respect of the selected referenced stock) over a specified period of time, applied to a notional amount that represents the value of a designated number of shares of the selected reference stock at the beginning of the equity swap contract. The fund also pays a floating rate that is based on short-term interest rates, applied to the notional amount. At the same time, the fund generally invests an amount approximating the notional amount of the swap in high-quality temporary cash investments.
A risk associated with all types of swaps is the possibility that a counterparty may default on its obligation to pay net amounts due to the fund. The fund's maximum amount subject to counterparty risk is the unrealized appreciation on the swap contract. The fund mitigates its counterparty risk by entering into swaps only with a diverse group of prequalified counterparties, monitoring their financial strength, entering into master netting arrangements with its counterparties, and requiring its counterparties to transfer collateral as security for their performance. In the absence of a default, the collateral pledged or received by the fund cannot be repledged, resold, or rehypothecated. In the event of a counterparty's default (including bankruptcy), the fund may terminate any swap contracts with that counterparty, determine the net amount owed by either party in accordance with its master netting arrangements, and sell or retain any collateral held up to the net amount owed to the fund under the master netting arrangements. The swap contracts contain provisions whereby a counterparty may terminate open contracts if the fund's net assets decline below a certain level, triggering a payment by the fund if the fund is in a net liability position at the time of the termination. The payment amount would be reduced by any collateral the fund has pledged. Any securities pledged as collateral for open contracts are noted in the Schedule of Investments. The value of collateral received or pledged is compared daily to the value of the swap contracts exposure with each counterparty, and any difference, if in excess of a specified minimum transfer amount, is adjusted and settled within two business days.
The notional amounts of swap contracts are not recorded in the Statement of Assets and Liabilities. Swaps are valued daily based on market quotations received from independent pricing services or recognized dealers and the change in value is recorded in the Statement of Assets and Liabilities as an asset (liability) and in the Statement of Operations as unrealized appreciation (depreciation) until periodic payments are made or the termination of the swap, at which time realized gain (loss) is recorded.
During the six months ended July 31, 2026, the fund's average amounts of investments in total return swaps represented less than 1% of net assets, based on the average of notional amounts at each quarter-end during the period.
4. Federal Income Taxes: The fund intends to continue to qualify as a regulated investment company and distribute virtually all of its taxable income. The fund's tax returns are open to examination by the relevant tax authorities until expiration of the applicable statute of limitations, which is generally three years after the filing of the tax return. Management has analyzed the fund's tax positions taken for all open federal and state income tax years, and has concluded that no provision for income tax is required in the fund's financial statements.
5. Distributions: Distributions to shareholders are recorded on the ex-dividend date. Distributions are determined on a tax basis at the fiscal year-end and may differ from net investment income and realized capital gains for financial reporting purposes.
12
Dividend Appreciation Index Fund
6. Securities Lending: To earn additional income, the fund lends its securities to qualified institutional borrowers. Security loans are subject to termination by the fund at any time, and are required to be secured at all times by collateral in an amount at least equal to the market value of securities loaned. Daily market fluctuations could cause the value of loaned securities to be more or less than the value of the collateral received. When this occurs, the collateral is adjusted and settled before the opening of the market on the next business day. The fund further mitigates its counterparty risk by entering into securities lending transactions only with a diverse group of prequalified counterparties, monitoring their financial strength, and entering into master securities lending agreements with its counterparties. The master securities lending agreements provide that, in the event of a counterparty's default (including bankruptcy), the fund may terminate any loans with that borrower, determine the net amount owed, and sell or retain the collateral up to the net amount owed to the fund; however, such actions may be subject to legal proceedings. While collateral mitigates counterparty risk, in the event of a default, the fund may experience delays and costs in recovering the securities loaned. The fund invests cash collateral received in Vanguard Market Liquidity Fund, and records a liability in the Statement of Assets and Liabilities for the return of the collateral, during the period the securities are on loan. Collateral investments in Vanguard Market Liquidity Fund are subject to market appreciation or depreciation. Securities lending income represents fees charged to borrowers plus income earned on invested cash collateral, less expenses associated with the loan. During the term of the loan, the fund is entitled to all distributions made on or in respect of the loaned securities.
7. Credit Facilities and Interfund Lending Program: The fund and certain other funds managed by The Vanguard Group ("Vanguard") participate in a $4.3 billion committed credit facility provided by a syndicate of lenders pursuant to a credit agreement and an uncommitted credit facility provided by Vanguard. Both facilities may be renewed annually. Each fund is individually liable for its borrowings, if any, under the credit facilities. Borrowings may be utilized for temporary or emergency purposes and are subject to the fund's regulatory and contractual borrowing restrictions. With respect to the committed credit facility, the participating funds are charged administrative fees and an annual commitment fee of 0.10% of the undrawn committed amount of the facility, which are allocated to the funds based on a method approved by the fund's board of trustees and included in Management and Administrative expenses on the fund's Statement of Operations. Any borrowings under either facility bear interest at the higher of the effective federal funds rate, the overnight bank funding rate, or the Daily Simple Secured Overnight Financing Rate. However, borrowings under the uncommitted credit facility may bear interest based upon an alternate rate agreed to by the fund and Vanguard.
In accordance with an exemptive order (the "Order") from the SEC, the fund may participate in a joint lending and borrowing program that allows registered open-end Vanguard funds to borrow money from and lend money to each other for temporary or emergency purposes (the "Interfund Lending Program"), subject to compliance with the terms and conditions of the Order, and to the extent permitted by the fund's investment objective and investment policies. Interfund loans and borrowings normally extend overnight but can have a maximum duration of seven days. Loans may be called on one business day's notice. The interest rate to be charged is governed by the conditions of the Order and internal procedures adopted by the board of trustees. The board of trustees is responsible for overseeing the Interfund Lending Program.
For the six months ended July 31, 2026, the fund did not utilize the credit facilities or the Interfund Lending Program.
8. Other: Dividend income is recorded on the ex-dividend date. Non-cash dividends included in income, if any, are recorded at the fair value of the securities received. Interest income includes income distributions received from Vanguard Market Liquidity Fund is accrued daily. Security transactions are accounted for on the date securities are bought or sold. Costs used to determine realized gains (losses) on the sale of investment securities are those of the specific securities sold.
Each class of shares has equal rights as to assets and earnings, except that each class separately bears certain class-specific expenses related to maintenance of shareholder accounts (included in Management and Administrative expenses) and shareholder reporting. Marketing and distribution expenses are allocated to each class of shares based on a method approved by the board of trustees. Income, other non-class-specific expenses, and gains and losses on investments are allocated to each class of shares based on its relative net assets.
B.
Vanguard provides investment advisory services to the fund through its wholly owned subsidiary Vanguard Portfolio Management, LLC.
C.
In accordance with the terms of a Funds' Service Agreement (the "FSA") between Vanguard and the fund, Vanguard furnishes to the fund
investment advisory, corporate management, administrative, marketing, and distribution services at Vanguard's cost of operations (as defined by the
FSA). These costs of operations are allocated to the fund based on methods and guidelines approved by the board of trustees and are generally
settled twice a month.
Upon the request of Vanguard, the fund may invest up to 0.40% of its net assets as capital in Vanguard. At July 31, 2026, the fund had contributed to Vanguard capital in the amount of $2,771,000, representing less than 0.01% of the fund's net assets and 1.11% of Vanguard's capital received pursuant to the FSA. The fund's trustees and officers are also directors and employees, respectively, of Vanguard.
D.
Various inputs may be used to determine the value of the fund's investments and derivatives. These inputs are summarized in three broad levels for
financial statement purposes. The inputs or methodologies used to value securities are not necessarily an indication of the risk associated with
investing in those securities.
Level 1-Quoted prices in active markets for identical securities.
Level 2-Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3-Significant unobservable inputs (including the fund's own assumptions used to determine the fair value of investments). Any investments and derivatives valued with significant unobservable inputs are noted on the Schedule of Investments.
13
Dividend Appreciation Index Fund
The following table summarizes the market value of the fund's investments and derivatives as of July 31, 2026, based on the inputs used to value them: 
Level 1
($000)
Level 2
($000)
Level 3
($000)
Total
($000)
Investments 
Assets
Common Stocks
130,407,201
-
-
130,407,201
Temporary Cash Investments
394,886
-
-
394,886
Total
130,802,087
-
-
130,802,087
 
Derivative Financial Instruments 
Assets
Swap Contracts
-
3,645
-
3,645
Liabilities
Futures Contracts1
(547)
-
-
(547)
Swap Contracts
-
(2,672)
-
(2,672)
Total
(547)
(2,672)
-
(3,219)
 
1
Includes cumulative appreciation (depreciation) on futures contracts and centrally cleared swaps, if any, as reported in the Schedule of Investments. Only current day's variation margin is reported within the Statement
of Assets and Liabilities.
E.
As of July 31, 2026, gross unrealized appreciation and depreciation for investments and derivatives based on cost for U.S. federal income tax purposes were as follows: 
Amount
($000)
Tax Cost
78,264,527
Gross Unrealized Appreciation
54,103,034
Gross Unrealized Depreciation
(1,566,021)
Net Unrealized Appreciation (Depreciation)
52,537,013
The fund's tax-basis capital gains and losses are determined only at the end of each fiscal year. For tax purposes, at January 31, 2026, the fund had available capital losses totaling $4,465,404,000 that may be carried forward indefinitely to offset future net capital gains. The fund will use these capital losses to offset net taxable capital gains, if any, realized during the year ending January 31, 2027; should the fund realize net capital losses for the year, the losses will be added to the loss carryforward balance above.
F.
During the six months ended July 31, 2026, the fund purchased $4,682,955,000 of investment securities and sold $4,350,510,000 of investment securities, other than temporary cash investments. In addition, the fund purchased and sold investment securities of $5,246,671,000 and $4,141,098,000, respectively, in connection with in-kind purchases and redemptions of the fund's capital shares.
The fund purchased securities from and sold securities to other Vanguard funds or accounts managed by Vanguard or its affiliates, in accordance with procedures adopted by the board of trustees in compliance with Rule 17a-7 of the Investment Company Act of 1940. For the six months ended July 31, 2026, such purchases were $594,678,000 and sales were $578,460,000, resulting in net realized loss of $69,783,000; these amounts, other than temporary cash investments, are included in the purchases and sales of investment securities noted above.
G.
Capital share transactions for each class of shares were:
 
Six Months Ended
July 31, 2026
Year Ended
January 31, 2026
Amount
($000)
Shares
(000)
Amount
($000)
Shares
(000)
ETF Shares
Issued
5,542,414
24,694
11,071,909
54,943
Issued in Lieu of Cash Distributions
-
-
-
-
Redeemed
(4,239,565)
(19,175)
(7,434,349)
(36,800)
Net Increase (Decrease)-ETF Shares
1,302,849
5,519
3,637,560
18,143
Admiral Shares
Issued
1,040,304
16,850
2,704,097
47,722
Issued in Lieu of Cash Distributions
123,018
2,032
239,326
4,241
Redeemed
(1,297,618)
(20,901)
(2,590,928)
(46,202)
Net Increase (Decrease)-Admiral Shares
(134,296)
(2,019)
352,495
5,761
H.
Significant market disruptions, such as those caused by pandemics, natural or environmental disasters, war, acts of terrorism, political or regulatory
conditions, or other events, can adversely affect local and global markets and normal market operations. Any such disruptions could have an adverse
impact on the value of the fund's investments and fund performance.
14
Dividend Appreciation Index Fund
To the extent the fund's investment portfolio reflects concentration in a particular market, industry, sector, country or asset class, the fund may be adversely affected by the performance of these concentrations and may be subject to increased price volatility and other risks.
The use of derivatives may expose the fund to various risks. Derivatives can be highly volatile, and any initial investment is generally small relative to the notional amount so that transactions may be leveraged in terms of market exposure. A relatively small market movement may have a potentially larger impact on derivatives than on standard securities. Leveraged derivatives positions can, therefore, increase volatility. Additional information regarding the fund's use of derivative(s) and the specific risks associated is described under significant accounting policies.
I.
Operating segments are components of an entity that engage in business activities, have discrete financial information available, and have their
operating results regularly reviewed by a chief operating decision maker ("CODM"). The fund is considered a single segment. Vanguard's chief
executive officer, chief investment officer, and chief financial officer, who are also officers of the fund, as well as the fund's chief financial officer
collectively act as the CODM. Vanguard has established various management committees to assist the CODM with overseeing aspects of the fund's
daily operations. Through these committees, the CODM manages the fund's operations to achieve a single investment objective, as detailed in its
prospectus, through the execution of the fund's investment strategies. When assessing segment performance and making decisions about segment
resources, the CODM relies on the fund's portfolio composition, total returns, expense ratios and changes in net assets which are consistent with the
information contained in the fund's financial statements. Segment assets, liabilities, income, and expenses are also detailed in the accompanying
financial statements.
J.
Management has determined that no subsequent events or transactions occurred through the date the financial statements were issued that would
require recognition or disclosure in these financial statements.
Q6022 092026
15

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies.

Not applicable.

Item 9: Proxy Disclosures for Open-End Management Investment Companies.

Not applicable.

Item 10: Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.

Not applicable. The Trustees' Fees and Expenses are included in the financial statements filed under Item 7 of this Form.

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contracts.

Trustees Approve Advisory Arrangement - Dividend Appreciation Index Fund

A majority of independent trustees of the board of Vanguard Dividend Appreciation Index Fund (Trustees) have renewed the fund's investment advisory arrangement with The Vanguard Group, Inc. (Vanguard), which provides investment advisory services to the fund through its subsidiary, Vanguard Portfolio Management LLC (VPM). The trustees determined that continuing the advisory arrangement was in the best interests of the fund and its shareholders.

The Trustees based their decisions upon an evaluation of VPM's investment staff, portfolio management process, and performance. This evaluation included information provided by Vanguard's Oversight and Manager Search team, which is responsible for fund and advisor oversight and product management.

The Oversight and Manager Search team met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed the Trustees' focus to relevant information and topics.

The board, or an investment committee made up of Trustees, also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.

In addition, the Trustees received periodic reports throughout the year, which included information about the fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.

Prior to their meeting, the trustees were provided with a memo and materials that summarized the information they received over the course of the year. The Trustees considered the factors discussed below, among others. However, no single factor determined whether to approve the arrangement. Rather, it was the totality of the circumstances that drove the Trustee's decisions.

Nature, extent, and quality of services

The Trustees considered the quality of the investment management services over both the short and long term and took into account the organizational depth and stability of Vanguard and VPM. The Trustees considered that Vanguard has been managing investments for more than four decades. The Strategic Equity Index Management team (SE), now within VPM, adheres to the same sound, disciplined investment management process and has considerable experience, stability and depth. In its management of other Vanguard passive and active equity funds and portfolios, the team has a track record of consistent performance as a result of its disciplined investment processes. SE has specific expertise and experience managing U.S. style-box, sector, and smart-beta index strategies, effectively navigating index reconstitutions and mitigating transactions costs to deliver tight tracking error while opportunistically seeking to add excess returns through sophisticated trading strategies and superior access to corporate actions.

The Trustees concluded that VPM's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.

Investment performance

The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.

Cost

The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory expenses were also below the peer-group average.

The Trustees do not conduct a profitability analysis of Vanguard in providing investment advisory services through VPM because of Vanguard's unique structure. Unlike most other mutual fund management companies, Vanguard is owned by the funds it oversees.

The benefit of economies of scale

The Trustees concluded that the fund's arrangement with Vanguard, and services rendered through VPM, ensure that the fund will realize economies of scale as it grows, with the cost to shareholders declining as fund assets increase.

The Trustees will consider whether to renew the advisory arrangement again within a one-year period.

Trustees Approve Advisory Arrangement - Energy Opportunities Fund

A majority of independent trustees of the board of Vanguard Energy Opportunities Fund (Trustees) has renewed the fund's investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The Trustees determined that renewing the fund's advisory arrangement was in the best interests of the fund and its shareholders.

The Trustees based their decision upon an evaluation of the advisor's investment staff, portfolio management process, and performance. This evaluation included information provided to the Trustees by Vanguard's Oversight and Manager Search team (OMS), which is responsible for fund and advisor oversight and product management. OMS met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed their focus to relevant information and topics.

The Trustees also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.

In addition, the Trustees received periodic reports throughout the year, which included information about each fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.

Prior to their meeting, the Trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the Trustees approved the arrangement. Rather, it was the totality of the circumstances that drove the Trustees' decision.

Nature, extent, and quality of services

The Trustees reviewed the quality of the fund's investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation's oldest and most respected institutional investment managers. The investment team uses a bottom-up approach in which stocks are selected based on the advisor's estimates of fundamental investment value. Fundamental research focuses on the quality of a company's assets, the company's internal reinvestment opportunities, and management quality. The firm has advised the fund since its inception in 1984.

The Trustees concluded that the advisor's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.

Investment performance

The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.

Cost

The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory fee rate was also below the peer-group average.

The Trustees did not consider the profitability of Wellington Management in determining whether to approve the advisory fee, because Wellington Management is independent of Vanguard and the advisory fee is the result of arm's-length negotiations.

The benefit of economies of scale

The Trustees concluded that the fund's shareholders benefit from economies of scale because of breakpoints in the fund's advisory fee schedule. The breakpoints reduce the effective rate of the fee as the fund's assets increase.

The Trustees will consider whether to renew the advisory arrangement again within a one-year period.

Trustees Approve Advisory Arrangement - Health Care Fund

A majority of independent trustees of the board of Vanguard Health Care Fund (Trustees) has renewed the fund's investment advisory arrangement with Wellington Management Company LLP (Wellington Management). The Trustees determined that renewing the fund's advisory arrangement was in the best interests of the fund and its shareholders.

The Trustees based their decision upon an evaluation of the advisor's investment staff, portfolio management process, and performance. This evaluation included information provided to the Trustees by Vanguard's Oversight and Manager Search team (OMS), which is responsible for fund and advisor oversight and product management. OMS met regularly with the advisor and made presentations to the Trustees during the fiscal year that directed their focus to relevant information and topics.

The Trustees also received information throughout the year during advisor presentations conducted by the Oversight and Manager Search team. For each advisor presentation, the Trustees were provided with letters and reports that included information about, among other things, the advisory firm and the advisor's assessment of the investment environment, portfolio performance, and portfolio characteristics.

In addition, the Trustees received periodic reports throughout the year, which included information about each fund's performance relative to its peers and benchmark, as applicable, and updates, as needed, on the Oversight and Manager Search team's ongoing assessment of the advisor.

Prior to their meeting, the Trustees were provided with a memo and materials that summarized the information they received over the course of the year. They also considered the factors discussed below, among others. However, no single factor determined whether the Trustees approved the arrangement. Rather, it was the totality of the circumstances that drove the Trustees' decision.

Nature, extent, and quality of services

The Trustees reviewed the quality of the fund's investment management services over both the short and long term and took into account the organizational depth and stability of the advisor. The board considered that Wellington Management, founded in 1928, is among the nation's oldest and most respected institutional investment managers. The portfolio manager is aided by a team of experienced Global Industry Analysts who cover health care industries. This health care team uses intensive fundamental analysis and deep knowledge of health care science and technology to identify companies with high-quality balance sheets, strong management, and the potential for new products that will lead to above-average growth in revenue and earnings. The advisor invests in stocks broadly representing the health care industry, seeking to maintain exposure across five primary subsectors: large-cap biotech/pharmaceuticals, mid-cap biotech/pharmaceuticals, small-cap biotech/pharmaceuticals, health care services, and medical technology. Wellington Management has advised the fund since its inception in 1984.

The Trustees concluded that the advisor's experience, stability, depth, and performance, among other factors, warranted continuation of the advisory arrangement.

Investment performance

The Trustees considered the fund's short- and long-term performance, including any periods of outperformance or underperformance compared with a relevant benchmark index and peer group. The Trustees concluded the performance was such that the advisory arrangement should continue.

Cost

The Trustees concluded that the fund's expense ratio was below the average expense ratio charged by funds in its peer group and that the fund's advisory fee rate was also below the peer-group average.

The Trustees did not consider the profitability of Wellington Management in determining whether to approve the advisory fee, because Wellington Management is independent of Vanguard and the advisory fee is the result of arm's-length negotiations.

The benefit of economies of scale

The Trustees concluded that the fund's shareholders benefit from economies of scale because of breakpoints in the fund's advisory fee schedule. The breakpoints reduce the effective rate of the fee as the fund's assets increase.

The Trustees will consider whether to renew the advisory arrangement again within a one-year period.

Item 12: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 13: Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 14: Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 15: Submission of Matters to a Vote of Security Holders.

Not applicable.

Item 16: Controls and Procedures.

(a) Disclosure Controls and Procedures. The Principal Executive and Financial Officers concluded that the Registrant's Disclosure Controls and Procedures are effective based on their evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.

(b) Internal Control Over Financial Reporting. There were no changes in the Registrant's Internal Control Over Financial Reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 17: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 18: Recovery of Erroneously Awarded Compensation

Not applicable.

Item 19: Exhibits.

(a)(1) Not applicable.
(a)(2) Certifications filed herewith.
(a)(2) Certifications filed herewith.

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VANGUARD SPECIALIZED FUNDS
BY: /s/ SALIM RAMJI*
      SALIM RAMJI
CHIEF EXECUTIVE OFFICER

Date: September 21, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

VANGUARD SPECIALIZED FUNDS
BY: /s/ SALIM RAMJI*
      SALIM RAMJI
CHIEF EXECUTIVE OFFICER

Date: September 21, 2026

VANGUARD SPECIALIZED FUNDS
BY: /s/ CHRISTINE BUCHANAN*
      CHRISTINE BUCHANAN
CHIEF FINANCIAL OFFICER

Date: September 21, 2026

* By: /s/ Natalie Lamarque

Natalie Lamarque, pursuant to a Power of Attorney filed on December 19, 2025 (see File Number 33-49023), and to a Power of Attorney filed on February 27, 2026 (see File Number 333-177613), Incorporated by Reference.

Vanguard Specialized Funds published this content on October 01, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 01, 2026 at 13:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]